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Introduction
INTRODUCTION
Historical Aspects
In 1850, Brodie described the clinical features of a 31-year-old man with an
ankylosed  spine  who “occasionally  suffered  severe  inflammation  of  the  eye.  (1)”  In
1884, Struempell from Leipzig, Germany, described two patients with complete
ankylosis of the spine and hip joints.(2) This report was soon followed by descriptions
of the disease by von Bechterew from St. Petersburg, Russia, and Marie from Paris,
France.(3,4) Although Roentgen had developed his radiographic technique by 1896, it
was not until 1930 that sacroiliac disease, now considered the radiographic hallmark
of AS, was fully recognized.
Spondyloarthropathy is a group of chronic inflammatory disorders of
unknown cause often associated with human leukocyte antigen (HLA)-B27
(Schumacher and Bardin 1998) which  includes ankylosing spondylitis (van der
Linden and van der Heijde 1998), reactive arthritis (Keat 1999), psoriatic arthritis
(Espinoza  et  al.  1992),  arthritis  associated  with  inflammatory  bowel  disease  (De
Keyser et al. 1998), acute anterior uveitis (Rosenbaum 1992), and undifferentiated
spondyloarthropathies (Zeidler et al. 1992). A childhood form juvenile
spondyloarthropathy also exists (Veys et al. 1995). The spondyloarthropathies share
common clinical, radiological, and genetic features that are clearly distinct from other
inflammatory rheumatic diseases. (5)
Terminology
Wright and Moll introduced the concept initially using the term seronegative
polyarthritis (Wright and Moll 1976), which was eventually changed to
spondyloarthropathy but in 2002, however, the Assessment in Ankylosing Spondylitis
(ASAS) international working group replaced spondyloarthropathy with
spondyloarthritis to stress that these are inflammatory diseases.(7) The term relates
not only to the spine and the peripheral joints but also refers to other structures, which
are involved in the disease process (the enthesis, the eye, the gut) (Franaois et al.
1995; Braun and Sieper 1996). The adjective seronegative is useless, since the
absence of the rheumatoid factor is the primary characteristic of patients included in
the  concept  and  the  term is  confusing  with  its  most  common use  in  relation  to  HIV
infection.
General Considerations
Axial skeletal involvement predominates in ankylosing spondylitis, which
invariably involves the sacroiliac joints and typically presents with the insidious onset
of inflammatory low back pain during late adolescence or early adulthood. Onset of
symptoms after the age of 40 is uncommon. Although the disease rarely begins after
the age of 40 years, it is not uncommon for the diagnosis to be made only years later,
well after that age. (9)
Although environmental factors are important in the development of
ankylosing spondylitis, the environmental triggers appear to be ubiquitous, and
genetic background is the major determinant of susceptibility to ankylosing
spondylitis. The only known susceptibility gene, HLA-B27, confers a relative risk of
close to 100 but probably accounts for only 10–50% of the overall genetic risk for
ankylosing spondylitis. The disease course varies considerably, ranging from mild
disease with little impact on functional status to severe disease that produces
substantial disability. The extent of spinal involvement is a major determinant of the
impact of the disease on functional status. Unfortunately, there are no reliable
predictors of long-term functional outcome early in the disease course. On average, 9
years elapse between the onset of symptoms and the diagnosis of ankylosing
spondylitis.  Several  factors  contribute  to  this  delay:  (1)  The  onset  of  low  back
symptoms is insidious, and patients may delay seeking medical attention. (2)
Mechanical low back pain is prevalent, and patients with ankylosing spondylitis are
often misdiagnosed as having that disorder. (3) It can be difficult to diagnose
ankylosing spondylitis in its early stages. Radiographic evidence of bilateral
sacroiliitis, which is the most definitive finding, usually takes several years to
develop. (4) There are no diagnostic criteria for the disease. The widely used modified
New York Criteria for the classification of ankylosing spondylitis require unequivocal
radiographic evidence of sacroiliitis and have limited sensitivity for early disease.The
disease can be accompanied by extraskeletal manifestations such as acute anterior
uveitis, aortic incompetence, cardiac conduction defects, and fibrosis of the upper
lobes of the lungs, neurologic involvement, or renal (secondary) amyloidosis.
AS has causes significant pain, disability, and social burden around the world.
Though once considered it as a non costly disease now become costly as favourable
results of treating AS with anti–tumor necrosis factor (TNF) agents have largely
redefined the entire therapeutic approach to this disease.
Classification of Spondyloarthropathies
? Ankylosing spondylitis
? Reiter’s syndrome or reactive arthritis
? Arthropathy of inflammatory bowel disease (Crohn’s, Ulcerative colitis
? Psoriatic arthritis
? Undifferentiated spondyloarthropathies
? Juvenile chronic arthritis and Juvenile onset ankylosing spondylylitis
Clinical characteristic of spondyloarthropathies
? Typical pattern of peripheral arthritis –predominantly of lower limb,
asymmetric
? Tendency toward radiographic sacroiliitis
? Presence of extra articular features (e.g., anterior uveitis)
? Significant familial aggregation
? Association with HLA-B27
? Absence of rheumatoid factor
? Absence of subcutaneous nodules and other extra articular features of
rheumatoid arthritis
Classification Criteria For Spondyloarthropathies (9)
We have the European Spondyloarthropathy Study Group (ESSG) criteria,
though clearly not intended for diagnostic purposes, and might be useful to identify
atypical and undifferentiated forms of spondyloarthropathies. This set of criteria
performed quite well in patients with different sociocultural and geographic
characteristics resulted in a sensitivity of 86% and a specificity of 87%.
? Inflammatory spinal pain or
? Synovitis (asymmetric, predominantly in lower limbs) and  any one of the
following (sensitivity, 77%; specificity, 89):
? Positive family history
? Psoriasis
? Inflammatory bowel disease
? Alternate buttock pain
? Enthesopathy
Adding sacroiliitis, sensitivity, 86%; specificity, 87%
The diagnosis of AS is based on clinical features. The disease is “primary” or
“idiopathic” if no associated disorder is present; it is “secondary” if the disease is
ssociated with psoriasis or chronic inflammatory bowel disease.
Modified New York, 1984 criteria (10)
o Low back pain of at least 3 months' duration improved by exercise and not
relieved by rest
o Limitation of lumbar spine motion in sagittal and frontal planes
o Chest expansion decreased relative to normal values for age and sex
o Bilateral sacroiliitis grade 2 to 4
o Unilateral sacroiliitis grade 3 or 4
Definite Ankylosing Spondylitis
Unilateral  grade  3  or  4,  or  bilateral  grade  2  to  4  sacroiliitis  and  any  clinical
criterion.
Epidemiology (11)
The prevalence of AS are closely parallels the frequency of HLA-B27. This
holds true for those B27 subtypes that are associated with the disease, but it is not true
for populations in which certain subtypes that lack an association with AS occur
rather frequently, such as the Indonesian population. (12,13).
Among whites, the estimated prevalence rate of AS as defined by the modified
New York criteria ranges from 68 per 100,000 populations older than 20 years in the
Netherlands to 197 per 100,000 in the United States.(14-16) The prevalence of
clinical AS in France is 150 per 100,000 adults, whereas in Norway it is 210 per
100,000 adults.(17,18) The prevalence of the disease in Finland is similar, with a
figure of 150 per 100,000 people.(19) Higher prevalence rates have been reported in
central Europe.
An epidemiologic study from Berlin reported a prevalence figure of 0.86%.
(20) In the general population, AS is likely to develop in about 1% to 2% of HLA-
B27–positive adults who have a disease-associated B27 subtype, although there may
be regional or geographic differences. For example, in northern Norway, AS may
develop in 6.7% of HLA-B27–positive people.(21)The disease is much more common
among HLA-B27–positive first-degree relatives of HLA-B27–positive AS patients;
roughly 10% to 30% of them have signs or symptoms of AS. Family history of AS, is
a strong risk factor for the disease.
An Indian study has shown that in South India, HLA-B27 is 83% positive,
(22) while it is positive in 94% of AS patients in North India. (23) HLA-A locus has
been associated with uveitis in North India and HLA A2 has been found increased
frequency in Pune study.(24)  HLA CW2 has been found in 50.9% of AS patients in
South India.(22)
Incidence and Prevalence
There is no adequate evidence that the incidence of AS has changed in the last
few decades. Clinical features, age of onset, and survival time have remained
stable.(25) One study revealed an overall age and gender-adjusted incidence of 7.3 per
100,000 person-years. This U.S. figure compares quite well with the Finnish study,
which revealed a stable incidence of 8.7 (95% confidence interval [CI] 6.4 to 11.0)
per 100,000 people aged 16 or older. In aggregate the spondyloarthropathies have a
prevalence estimated between 0.5% and 1.9%.
Racial Distribution
AS is presents in all parts of the world. Approximately 90% of white patients
with AS possess HLA-B27, whereas AS and HLA-B27 are nearly absent (prevalence
of B27 < 1%) in African blacks and Japanese.
In African Americans, owing to racial admixture with whites, 2% possess
B27, but only about 50% of black patients with AS possess B27. Correspondingly,
African Americans are affected far less frequently than American whites.
Gender Issues
Clinically, AS is more common in males, with a reported male-female ratio of
about 2:1 to 3:1. (26, 27) However, extrapolation of studies employing the genetic
marker  HLA-B27  suggests  that,  based  on  radiographs  of  the  sacroiliac  joints,
prevalence rates are about equal in both sexes. (12) Whereas, case study report from
Rheumatic Care Centre, Chennai has shown the ratio of 18.7:1. (28).
Disease expression is thought to be different in males and females. A case-
control study comparing 35 female patients to 70 male patients as controls showed no
differences in spinal symptoms, chest expansion, peripheral arthritis, extra-articular
manifestations, or functional outcome. The males with AS more often had
radiographic spinal changes and hip joint involvement than their female counterparts.
There is still some controversy, but overall, there are no significant clinical or
radiographic differences between women and men with AS. However, on average, the
disease seems to be more severe in men.(26, 27)
Burden of Disease
AS, is associated with a considerable burden to the patient and the society.
Apart from the axial and articular manifestations, extra-articular manifestations, such
as enthesitis and acute anterior uveitis, and comorbidities, such as inflammatory
bowel disease and psoriasis,  contribute to the burden of disease.  In addition, a large
proportion of patients have spinal osteoporosis, leading to vertebral fractures and
thoracic kyphosis. All these features result in a decreased quality of life. The burden
of illness increases with duration of disease. Because the burden reduces quality of
life, and because all types of costs associated with AS result from loss of function and
disease activity, early diagnosis and treatment are necessary to prevent or reduce
functional decline and improve patient outcome.(29)
Anatomy of Sacroiliac Joints
The sacroiliac joint is the joint between the sacrum, at the base of the spine
and the Ilium of the pelvis, which are joined by ligaments. It is a strong, weight
bearing synovial joint with irregular elevations and depressions that produce
interlocking of the two bones.The sacroiliac joint presents a complex two
compartment anatomy (Diarthrodial joints). The synovial portion of the sacroiliac
joint is vertically oriented (lower 1/3), while the ligamentous (fibrous) portion
presents horizontal-oblique orientation (upper 2/3). The normal joint space of the
sacroiliac joint measures 2.5–4.0 mm (mean = 3.0 mm). The stability of the SIJs is
maintained mainly through a combination of both bony structure and very strong
intrinsic and extrinsic ligaments (anterior, posterior sacroiliac ligaments and strong
interosseous ligaments). As we age the characteristics of the sacroiliac joint change.
The joint's surface remains flat in early life but as we start walking, the joint surfaces
develop distinct angular orientations (lose their planar or flat topography.) They also
develop an elevated ridge along the ilial surface and a depression along the sacral
surface. The ridge and corresponding depression, along with the very strong
ligaments, increase the sacroiliac joints' stability and makes dislocations very rare.
The clinical diagnosis of early sacroiliitis is often difficult because of deep
location and lack of motion and also, frequently obscured by the overlying soft
tissues. For these features radiographic abnormalities are regarded as the most reliable
objective indicator of inflammatory spondyloarthropathies
Pathology
The enthesis, the site of attachment of tendon, ligaments, capsule and fascia to
bone, is thought to be the primary site of pathology in AS (30), particularly in the
lesions around the pelvis and spine. Enthesitis is associated with prominent edema of
the adjacent bone marrow and is often characterized by erosive lesions that eventually
undergo ossification.
Sacroiliitis is usually one of the earliest manifestations of AS, with features of
both enthesitis and synovitis. The early lesions consist of subchondral granulation
tissue, infiltrates of lymphocytes and macrophages in ligamentous and periosteal
zones, and subchondral bone marrow edema. Synovitis follows and may progress to
pannus formation with islands of new bone formation. The eroded joint margins are
gradually replaced by fibrocartilage regeneration and then by ossification. Ultimately,
the joint may be totally obliterated.
In the spine, early in the process there is inflammatory granulation tissue at the
junction of the annulus fibrosus of the disk cartilage and the margin of vertebral bone.
The outer annular fibers are eroded and eventually replaced by bone, forming the
beginning of a bony syndesmophyte, which then grows by continued enchondral
ossification, ultimately bridging the adjacent vertebral bodies. Ascending progression
of this process leads to the "bamboo spine" observed radiographically. Other lesions
in the spine include diffuse osteoporosis, erosion of vertebral bodies at the disk
margin, "squaring" of vertebrae, and inflammation and destruction of the disk-bone
border.  Inflammatory  arthritis  of  the  apophyseal  joints  is  common,  with  erosion  of
cartilage by pannus, often followed by bony ankylosis. Bone mineral density is
significantly diminished in the spine and proximal femur early in the course of the
disease, before the advent of significant immobilization. Peripheral arthritis in AS can
show synovial hyperplasia, lymphoid infiltration, and pannus formation, but the
process lacks the exuberant synovial villi, fibrin deposits, ulcers, and accumulations
of plasma cells seen in rheumatoid arthritis (RA). Central cartilaginous erosions
caused by proliferation of subchondral granulation tissue are common in AS but rare
in RA.
The  symptoms  of  the  disease  are  usually  first  noticed  in  late  adolescence  or
early adulthood; the median age in western countries is 23. In 5% of patients,
symptoms begin after age 40. The initial symptom is usually dull pain, insidious in
onset, felt deep in the lower lumbar or gluteal region, accompanied by low-back
morning  stiffness  of  up  to  a  few  hours'  duration  that  improves  with  activity  and
returns following periods of inactivity. Within a few months of onset, the pain has
usually become persistent and bilateral. Nocturnal exacerbation of pain that forces the
patient to rise and move around may be frequent.
In some patients, bony tenderness (presumably reflecting enthesitis) may
accompany back pain or stiffness, while in others it may be the predominant
complaint.Common sites include the costosternal junctions, spinous processes, iliac
crests, greater trochanters, ischial tuberosities, tibial tubercles, and heels.
Occasionally, bony chest pain is the presenting complaint. Arthritis in the hips and
shoulders ("root" joints) occurs in 25 to 35% of patients, in many cases early in the
disease course. Arthritis of peripheral joints other than the hips and shoulders, usually
asymmetric, occurs in up to 30% of patients and can occur at any stage of the disease.
Neck pain and stiffness from involvement of the cervical spine are usually
relatively late manifestations. Occasional patients, particularly in the older age group,
present with predominantly constitutional symptoms such as fatigue, anorexia, fever,
weight loss, or night sweats. AS often has a juvenile onset in developing countries.
(30) In these individuals, peripheral arthritis and enthesitis usually predominate, with
axial symptoms supervening in late adolescence.
Initially, physical findings mirror the inflammatory process. The most specific
findings involve loss of spinal mobility, with limitation of anterior and lateral flexion
and extension of the lumbar spine and of chest expansion. Limitation of motion is
usually out of proportion to the degree of bony ankylosis, reflecting muscle spasm
secondary to pain and inflammation. Pain in the sacroiliac joints may be elicited either
with direct pressure or with maneuvers that stress the joints. In addition, there is
commonly tenderness upon palpation at the sites of symptomatic bony tenderness and
paraspinous muscle spasm. The  modified  Schober  test  is  a  useful  measure
of lumbar spine flexion. The patient stands erect, with heels together, and marks are
made directly over the spine 5 cm below and 10 cm above the lumbosacral junction
(identified by a horizontal line between the posterosuperior iliac spines.) The patient
then bends forward maximally, and the distance between the two marks is measured.
The distance between the two marks increases by =5 cm in the case of normal
mobility and by <4 cm in the case of decreased mobility. Chest expansion is measured
as the difference between maximal inspiration and maximal forced expiration in the
fourth intercostal space in males or just below the breasts in females. Normal chest
expansion is =5 cm. Limitation or pain with motion of the hips or shoulders is usually
present if either of these joints is involved. It should be emphasized that early in the
course of mild cases, symptoms may be subtle and nonspecific, and the physical
examination may be completely normal.
The course of the disease is extremely variable, ranging from the individual
with mild stiffness and radiographically equivocal sacroiliitis to the patient with a
totally fused spine and severe bilateral hip arthritis, possibly accompanied by severe
peripheral arthritis and extraarticular manifestations. Pain tends to be persistent early
in the disease and then becomes intermittent, with alternating exacerbations and
quiescent periods. In a typical severe untreated case with progression of the
spondylitis to syndesmophyte formation, the patient's posture undergoes characteristic
changes, with obliterated lumbar lordosis, buttock atrophy, and accentuated thoracic
kyphosis. There may be a forward stoop of the neck or flexion contractures at the
hips, compensated by flexion at the knees. The progression of the disease may be
followed by measuring the patient's height, chest expansion, Schober test, and
occiput-to-wall distance. Occasional individuals are encountered with advanced
physical findings who report having never had significant symptoms.
In some but not all studies, onset of the disease in adolescence correlates with
a worse prognosis. Early severe hip involvement is an indication of progressive
disease. The disease in women tends to progress less frequently to total spinal
ankylosis, although there is some evidence for an increased prevalence of isolated
cervical ankylosis and peripheral arthritis in women. In industrialized countries,
peripheral arthritis (distal to hips and shoulders) occurs overall in about 25% of
patients, usually as a late manifestation, whereas in developing countries, the
prevalence is much higher, with onset typically early in the disease course. Pregnancy
has no consistent effect on AS, with symptoms improving, remaining the same, or
deteriorating in about one-third of pregnant patients, respectively.The most serious
complication of the spinal disease is spinal fracture, which can occur with even minor
trauma to the rigid, osteoporotic spine. The cervical spine is most commonly
involved. These fractures are often displaced and cause spinal cord injury.
The most common extraarticular manifestation is acute anterior uveitis, which
occurs  in  30%  of  patients  and  can  antedate  the  spondylitis.  Attacks  are  typically
unilateral, causing pain, photophobia, and increased lacrimation. These tend to recur,
often in the opposite eye. Cataracts and secondary glaucoma are not uncommon
sequelae. Up to 60% of patients have inflammation in the colon or ileum. This is
usually asymptomatic, but in 5 to 10% of patients with AS (30), frank IBD will
develop. Aortic insufficiency, sometimes producing symptoms of congestive heart
failure, occurs in a few percent of patients, occasionally early in the course of the
spinal disease but usually after prolonged disease. Third-degree heart block may occur
alone or together with aortic insufficiency. Subclinical pulmonary lesions and
cardiac dysfunction may be relatively common. Cauda equina syndrome and slowly
progressive upper pulmonary lobe fibrosis are rare complications of long-standing
AS. Retroperitoneal fibrosis is a rare associated condition. Prostatitis has been
reported to have an increased prevalence in men with AS. Amyloidosis is rare.
Several validated measures of disease activity and functional outcome have
recently been developed for AS (30). Despite the persistence of the disease, most
patients remain gainfully employed. The effect of AS on survival is controversial.
Some, but not all, studies have suggested that AS shortens life span, compared with
the general population. Mortality attributable to AS is largely the result of spinal
trauma, aortic insufficiency, respiratory failure, amyloid nephropathy, or
complications of therapy such as upper gastrointestinal hemorrhage.
Diagnostic Features of Ankylosing Spondylitis
? Inflammatory spinal pain
? Onset before age 40 yr
? Insidious onset
? Persistence for at least 3 months
? Morning stiffness of at least 30 min duration
? Improvement with exercise but not with rest
? Awakening because of back pain during second half of night
? Chest pain
? Alternate buttock pain
? Acute anterior uveitis
? Synovitis (predominantly of lower limbs, asymmetric)
? Enthesitis (heel, plantar)
? Radiographic sacroiliitis
? Positive family history of AS, IBD and Psoriasis
The pain is initially felt primarily deep in the gluteal region, is dull in character, is
difficult to localize, and is insidious in onset. The pain can be severe at this early
phase of the disease; it localizes in the sacroiliac joints but is occasionally referred
toward the iliac crest or greater trochanteric region or down the dorsal thigh.
Radiation of buttock pain may suggest root compression of the sciatic nerve. The
buttock pain typically alternates from side to side. Coughing, sneezing, or other
manoeuvres that cause a sudden twist of the back may accentuate pain. Although the
pain is often unilateral or intermittent at first, within a few months it usually becomes
persistent and bilateral, and the lower lumbar area becomes stiff and painful. The pain
is associated with a feeling of low back stiffness that is worse in the morning and may
awaken the patient from sleep, particularly during the second half of the night. Many
patients do not differentiate between low back pain and stiffness. The morning
stiffness may last up to 3 hours. Both the stiffness and the pain tend to be eased by a
hot shower, an exercise program, or physical activity; they do not improve with rest.
Fatigue as a result of chronic back pain and stiffness may be an important problem
and can be accentuated by sleep disturbances due to these symptoms.
Undifferentiated spondyloarthritis
uSpA is distinguished by an absence of ankylosing spondylitis, preceding infection, psoriasis,
ulcerative colitis, or Crohn's disease otherwise these group of patients shows all other features
of SpA.(7).
Reactive Arthritis (31-33)
Inflammatory arthritis triggered by antecedent gastrointestinal or genitourinary
infections.  Asymmetric oligoarthritis most commonly affecting the lower extremities.
Enthesitis and dactylitis. Association with extra-articular manifestations such as
conjunctivitis, anterior uveitis, urethritis, circinate balanitis, oral ulcers, and
keratoderma blennorrhagicum.
Reactive arthritis is a systemic inflammatory condition that is triggered by
bacterial infections of the gastrointestinal or genitourinary tracts. Despite the link with
infection, cultures of synovial fluid are sterile, and there is no established role for
antibiotics. "Reactive arthritis" should replace the term "Reiter syndrome," which
refers to the triad of reactive arthritis, conjunctivitis, and urethritis. "Reiter syndrome"
is confusing because many patients with reactive arthritis do not have all components
of the triad. Recent revelations concerning Reiter's involvement in war crimes during
World War II provide an additional reason to avoid this eponym.
Reactive arthritis typically develops 1 to 4 weeks after a bout of gastroenteritis
caused by Shigella, Salmonella, Campylobacter, or Yersinia, or after a genitourinary
tract infection with Chlamydia trachomatis. Recent reports indicate that enteric
infections with Clostridium difficile also can trigger reactive arthritis. Most cases are
sporadic, but reactive arthritis also can occur in clusters following outbreaks of
gastroenteritis. Sometimes there is no antecedent history of infection, suggesting that
reactive arthritis can follow subclinical infections or that other environmental triggers
are at play. Reactive arthritis usually develops in young adults between 20 and 40
years of age. Chlamydia-induced disease is more common in men; men and women
are at equal risk to develop post-enteric disease. The annual incidence of reactive
arthritis is estimated to be approximately 30 to 40 per 100,000.
Genetic factors have a role in susceptibility to reactive arthritis. Human
leukocyte antigen (HLA)-B27 is linked to reactive arthritis, but the strength of the
association is not as robust as that seen between HLA-B27 and ankylosing
spondylitis. The prevalence of HLA-B27 in series of reactive arthritis ranges from 50
to 80%, with the higher figures generally seen in cohorts with persistent disease. The
incidence  of  reactive  arthritis  tends  to  reflect  the  prevalence  of  HLA-B27  in
populations; in the United States, therefore, reactive arthritis is more common in
Caucasians (8% of whom have HLA-B27) than in African Americans, who have a far
lower frequency of HLA-B27. A notable exception to the link between reactive
arthritis and HLA-B27 is in sub-Saharan Africa, where an aggressive form of reactive
arthritis occurs in HLA-B27 negative individuals who are infected with human
immunodeficiency virus.
The course of reactive arthritis varies considerably. Mild conjunctivitis and
urethritis, which can be due either to infection with Chlamydia or to mucosal
inflammation in cases induced by enteric infection, may precede the onset of arthritis.
The arthritis is often low grade but can be severe and accompanied by significant
weight loss, fever, and other constitutional symptoms. Enthesitis is often a prominent
manifestation. Reactive arthritis can consist of a single attack that runs its course
within a matter of months. Alternatively, patients may experience self-limited attacks,
lasting weeks to months, which recur for years after the onset of initial symptoms. A
chronic, destructive, and disabling arthritis evolves in a minority of patients.
Unfortunately, there are no reliable predictors of long-term outcomes. Reactive
arthritis generally has less long-term morbidity and mortality than rheumatoid
arthritis.
Axial skeleton disease most commonly manifests as inflammatory low back
pain, which occurs in up to half of patients with reactive arthritis. Approximately 20-
25% of patients develop radiographic evidence of sacroiliitis, which is often
unilateral, and if bilateral, is asymmetric and thus distinct from the bilateral,
symmetric sacroiliitis of ankylosing spondylitis. In minority of patients, with
sacroiliitis have spondylitis as well; extensive fusion of the spine resembling severe
ankylosing spondylitis can develop but is uncommon. The prevalence of axial
skeleton disease is greater among those with chronic disease and those with HLA-B27
(90% of patients with radiographic evidence of sacroiliitis are HLA-B27 positive).
Enthesitis, mucocutaneous lesions, Circinate balanitis is an inflammatory lesion on
the  glans  or  shaft  of  the  penis,  and  it  is  one  of  the  characteristic  lesions  associated
with reactive arthritis. If the male is circumcised, these lesions can appear as multiple,
serpiginous, shallow ulcers with raised borders. In uncircumcised males, the lesions
can appear as dry, hyperkeratotic plaques that are reminiscent of psoriasis.
Urethritis can be a consequence of infection with Chlamydia but also can be a
manifestation of mucosal inflammation in cases of reactive arthritis triggered by
enteric infection. Prostatitis is common.
Another cutaneous lesion associated with reactive arthritis is keratoderma
blennorrhagicum, a skin rash that typically affects the palms and soles and is best
described as papular, waxy lesions which can evolve into scaly, hyperkeratotic lesions
resembling  psoriasis.  These  lesions  can  coalesce  to  cover  large  areas  of  skin,
extending proximally beyond the palms and soles of the feet. Keratoderma
blennorrhagicum cannot be distinguished histologically from pustular psoriasis.
Aphthous ulcerations can form in patients with reactive arthritis. These lesions
are often painless and develop along the oral or genital mucosa.
As occurs in psoriatic arthritis, nails can become thickened and develop
subungual debris and onychodystrophy. Pitting, however, does not occur. The clinical
appearance is similar to onychomycosis, and often the two are confused.
Conjunctivitis is common, particularly early in disease, and is usually mild
and self-limited. Uveitis occurs in up to one-fourth of cases and mainly affects the iris
and ciliary body (anterior uveitis). Uveitis causes photophobia and ocular pain and
can lead to visual impairment if not recognized and treated appropriately. Scleral
injection  is  often,  but  not  always,  present.  Diagnosis  requires  slitlamp  examination,
which reveals the presence of inflammatory cells and protein exudate in the anterior
chamber. Attacks of uveitis are usually monocular, last weeks to months, and tend to
recur (in either eye). Virtually all patients with reactive arthritis and uveitis are HLA-
B27 positive.
Inflammation of the interventricular septum can affect the atrioventricular
node, resulting in varying degrees of heart block. Aortitis is an uncommon
manifestation of long-standing reactive arthritis. Inflammation of the aortic root and
aortic valve can lead to aortic valve regurgitation.
Psoriatic Arthritis
Inflammatory  arthritis  associated  with  psoriasis.  Often  an  asymmetric,
peripheral oligoarthritis but monoarthritis, polyarthritis, and spondylitis occur as well.
Frequent involvement of the distal interphalangeal joints. Association with dactylitis,
enthesitis, and characteristic nail changes. Absence of rheumatoid factor
(seronegative). Radiographic findings of erosions or osteolytic destruction of the
interphalangeal joints, often with concomitant proliferative changes. (34-36)
Psoriatic arthritis is an inflammatory arthritis that occurs in association with
the skin disease psoriasis. It is one of the spondyloarthropathies, which characterized
by enthesitis, arthritis of the axial skeleton, an asymmetric oligoarthritis of peripheral
joints,  and  the  absence  of  rheumatoid  factor.  Psoriatic  arthritis  has  a  pred  distal
interphalangeal (DIP) joints.
Arthritis develops in approximately 10% of patients with psoriasis. The
overall prevalence of psoriatic arthritis has been estimated to be 0.04 to 0.1% of the
general population, but this may be an underestimate. In the United States, the
incidence of psoriatic arthritis has been reported to be approximately 6 to 7 per
100,000 per annum. The mean age of disease onset ranges from 30 to 55 years, with
men and women affected equally.The etiology of psoriatic arthritis is unknown. There
are confirmed associations with major histocompatibility alleles human leukocyte
antigen-B27, -B7, -B13, -B17, and -Cw6. As in the pathogenesis of many other
autoimmune disorders, an infectious trigger has been suspected. Group A
streptococcal infections have been implicated in guttate psoriasis, and ribosomal RNA
from this species has been detected in blood and synovial fluid of psoriatic arthritis
patients. In addition, the human immunodeficiency virus is strongly associated with
the development of psoriasis and psoriatic arthritis; the incidence and prevalence of
both psoriasis and psoriatic arthritis are substantially higher in individuals infected
with human immunodeficiency virus than in the general population.
Psoriatic arthritis typically develops after or coincident with the onset of psoriasis. In
15 to 20% of cases, however, arthritis precedes the onset of psoriasis by as much as 2
years. Asymmetric oligoarticular arthritis is the classic description of psoriatic
arthritis, but articular manifestations range from an isolated monoarthritis to
polyarthritis to widespread destructive arthritis (arthritis mutilans). The course of
psoriatic arthritis varies considerably. Unfortunately, no reliable markers for diagnosis
or predictors of long-term outcomes are available. There may be a direct correlation
between the severity of arthritis at the time of presentation and the subsequent clinical
course. As seen in rheumatoid arthritis, psoriatic arthritis can significantly impact
quality of life and physical function. Articular damage often develops, and destruction
of single joints can occur rapidly. Articular Involvement, the majority of patients with
psoriatic arthritis present with an oligo- or monoarthritis. Often the DIP joints become
stiff, swollen, and tender in an asymmetric fashion. When present, involvement of the
DIPs helps to distinguish psoriatic arthritis from rheumatoid arthritis, but sometimes
results in confusion with osteoarthritis. In a smaller proportion of patients, symptoms
begin in a symmetric fashion and involve the hands and feet in a pattern resembling
that of rheumatoid arthritis. Other joints that are affected by psoriatic arthritis include
the knees, hips, and sternoclavicular joints.
Nail Changes, as with uncomplicated psoriasis, nail involvement is common in
psoriatic arthritis Psoriatic nail changes include ridging, pitting, onycholysis,
dyschromic and hyperkeratosis, and may represent the only manifestation of psoriasis
before the presence of more characteristic skin lesions. Nail changes on the affected
finger virtually always occur when psoriatic arthritis affects a DIP joint.
Arthropathy of Inflammatory Bowel Disease
The first associations between bowel disease and arthritis were described in
the  early  1900s.  Despite  these  descriptions,  however,  the  distinct  entity  of
inflammatory arthritis occurring in patients with IBD was not accepted in the medical
community until after 1960. Currently, musculoskeletal involvement is the most
common  extraarticular  manifestation  of  IBD.  (37,  38)  The  etiology  of  IBD
arthropathy is unknown.  No HLA-B27 association has been established in patients
with peripheral arthritis or asymptomatic sacroiliitis. In contrast, 50% to 75% of IBD
patients with symptomatic spondylitis are HLA-B27 positive. Given these genetic and
clinical differences, researchers believe that a different pathogenesis may exist for
each group. Since HLA-B27 is associated with spondylitis patients, the pathogenesis
in this group may be similar to theories for idiopathic AS. (40) In the peripheral
arthritis subset, since clinical disease parallels bowel disease, mechanisms directly
related to gut inflammation might be more applicable. The incidence of peripheral
arthropathy in IBD patients is 15% to 20%, with a more frequent occurrence in
Crohn's disease (20%) than in ulcerative colitis (12%) patients. In addition, peripheral
arthritis is more frequently associated with colonic than with ileal involvement in
Crohn's disease. Peripheral joint involvement classically begins with or after the onset
of bowel disease. (41) Subsequent flares also parallel disease activity in the bowel.
Males and females are equally affected. Joint involvement is typically asymmetric,
oligoarticular, often migratory, and lasts for weeks to months but rarely becomes
chronic. The most common joint affected is the knee, followed by the ankle, elbow,
and  wrist.  Smaller  joint  involvement  occurs  less  often.  Enthesopathy,  such  as
tendinitis and plantar fasciitis, may develop. Other extraarticular features of IBD,
including the skin, mucous membranes, and eyes, often are concurrently active.
Erosive  deformities  rarely  develop  (less  than  10%) but  seem to  involve  large  joints,
particularly  hips  and  shoulders.  In  the  few  cases  of  erosive  arthropathy,
granulomatous synovitis may be responsible.
Axial Arthropathy
Two subsets of IBD-associated axial arthropathy exist: (1) asymptomatic
sacroiliitis noted on plain radiographs and (2) symptomatic axial disease clinically
indistinguishable from idiopathic AS. The incidence of asymptomatic sacroiliitis may
be as high as 29%, but frank AS occurs in only 2% to 8% of IBD patients. In contrast
to peripheral arthropathy, axial skeletal disease does not correlate with IBD activity.
Spondylitis often precedes the development of active bowel disease by many years,
thus making the diagnosis difficult. Unfortunately, even when IBD is under control or
in remission, axial disease may persist or progress. Men are affected more often than
women, but not to the degree in idiopathic AS. Classically, the symptoms of
inflammatory back pain develop insidiously. Peripheral arthritis may coexist with
axial disease and extraarticular features. (42)
Imaging Studies
Conventional Radiography
The typical radiographic changes of AS are seen primarily in the axial
skeleton, especially in the sacroiliac, discovertebral, apophyseal, costovertebral, and
costotransverse joints. They evolve over many years, with the earliest, most
consistent, and most characteristic findings seen in the sacroiliac joints. However,
otherwise typical AS has been described in the absence of radiographic evidence of
sacroiliitis.(15) The radiographic findings of sacroiliitis are usually symmetric and
consist of blurring of the subchondral bone plate, followed by erosions and sclerosis
of the adjacent bone. The changes in the synovial portion of the joint (i.e., the lower
one thirds of the joint) result from inflammatory synovitis and osteitis of the adjacent
subchondral bone. (43) The cartilage covering the iliac side of the joint is much
thinner than that covering the sacral side. Therefore, the erosions and subchondral
sclerosis are typically seen first and tend to be more prominent on the iliac side. (44)
In upper two third of the sacroiliac joint, there strong intra-articular ligaments hold the
bones together, the inflammatory process may lead to similar radiographic
abnormalities. Progression of the subchondral bone erosions can lead to
pseudowidening of the sacroiliac joint space. Over time, gradual fibrosis,
calcification, interosseous bridging, and ossification occur. Erosions become less
obvious, but the subchondral sclerosis persists, becoming the most prominent
radiographic feature. Ultimately, usually after several years, there may be complete
bony ankylosis of the sacroiliac joints, with resolution of bony sclerosis. (45, 46) It is
practical to grade radiographic sacroiliitis according to the New York criteria
Grading of Sacroiliitis: New York Criteria
Grade 0, normal
Grade 1, suspicious
Grade 2, minimal sacroiliitis
Grade 3, moderate sacroiliitis
Grade 4, ankylosis
Bony erosions and osteitis (“whiskering”) at sites of osseous attachment of
tendons and ligaments are frequently seen, particularly at the calcaneus, ischial
tuberosities, iliac crest, femoral trochanters, supraspinatus insertion, and spinous
processes of the vertebrae. In the early stages of the evolution of syndesmophytes,
there is inflammation of the superficial layers of the annulus fibrosus, with subsequent
reactive  sclerosis  and  erosions  of  the  adjacent  corners  of  the  vertebral  bodies.  This
combination of destructive osteitis and repair leads to “squaring” of the vertebral
bodies. This squaring is associated with gradual ossification of the annulus fibrosus
and eventual “bridging” between vertebrae by syndesmophytes. (47) There are often
concomitant inflammatory changes, ankylosis in the apophyseal joints, and
ossification of the adjacent ligaments. In a number of patients, this may ultimately
result in a virtually complete fusion of the vertebral column (“bamboo spine”).
Hip involvement may lead to symmetric, concentric joint space narrowing,
irregularity of the subchondral bone with subchondral sclerosis, osteophyte formation
at the outer margin of the articular surface, and, ultimately, bony ankylosis of these
joints.There are several validated scoring methods available to quantify structural
damage in AS: the Bath AS radiology index (BASRI), the Stoke AS spondylitis Score
(SASSS), and the modified SASSS. The BASRI includes scores for the cervical and
lumbar spine as well as the sacroiliac joints. A similar score for the hips is also
available. The SASSS evaluates the lumbar spine only; the modified SASSS assesses
the cervical and lumbar spine. These scoring methods are most suited for use in
clinical trials and observational studies.(48 – 50).
Computed Tomography and Magnetic Resonance Imaging
The conventional plain pelvic radiograph is still the initial tool for the
evaluation of sacroiliac joints in patients with inflammatory low back pain. This
technique, however, lacks sensitivity in the early stages of sacroiliac inflammation. In
such cases, dynamic MRI with a T1-weighted sequence after the intravenous injection
of gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA) is able to demonstrate
early stages of sacroiliitis. (51, 52)  Fat-saturating techniques such as short tau
inversion recovery (STIR) sequences are very sensitive in the detection of bone
marrow edema, which is a frequent finding in AS-related inflammation of the
musculoskeletal  system.  STIR  imaging  is  cheaper  than  Gd-DTPA  sequences  and
almost  as  good.  Thus,  active,  early  sacroiliitis  can  best  be  searched  for  by  STIR  or
contrast-based sequences.
Similarly, spinal involvement is first assessed by conventional radiography. Square
vertebrae, shiny corners (the Romanus lesion), spondylodiscitis (the Anderson lesion),
and syndesmophytes with partial and complete fusion are typical radiographic
features of AS.(53, 54) Spinal inflammation cannot be assessed by conventional
radiography but can be visualized by MRI where it is typically seen in the vertebrae,
at both anterior and posterior sites as well as around the intervertebral disk. Posterior
elements such as the facet joints, pedicles, and transverse processes can show
inflammatory  lesions  as  well.  MRI  can  be  very  useful  to  assess  enthesitic  problems
such as Achilles tendinitis and heel pain.(55, 56).
For  the  detection  of  bone  changes,  such  as  erosions  and  ankylosis,  CT  is
usually considered superior to MRI (57, 58), but MRI is better in the imaging of
cartilage and provides the possibility of dynamic measurements. (59) CT is definitely
not indicated in the routine evaluation of the sacroiliac joint. CT scanning may be
useful in the diagnosis of spinal fractures, spinal stenosis, or thecal diverticula. A
major difference between CT and MRI is the radiation exposure associated with the
former but not with the latter.
Power Doppler Imaging
Power Doppler imaging has recently gained attention in musculoskeletal
ultrasound as an extended arm of rheumatologist or as rheumatologist stethoscope and
even to be called as poor man MRI. Additionally, color flow imaging technique that
have overcomes some of the limitations of conventional color Doppler ultrasound
(US). Limitations of conventional color Doppler US include angle dependence,
aliasing, and difficulty in separating background noise from true flow in slow-flow
states. Owing to its increased sensitivity to flow, power Doppler Sonography is
valuable in low-flow states and when optimal Doppler angles cannot be obtained (60).
Over the last decade, real-time ultrasound has emerged as one of the leading
contenders to be the ideal musculoskeletal imaging modality, capable of combining
both morphological and functional imaging in musculoskeletal soft tissues. Increasing
numbers of rheumatologists have been using grey-scale, colour and power Doppler
ultrasonography not just as a research tool, but also—especially in many European
countries—in daily rheumatological practice. It is now included in the rheumatology
curriculum of many different European countries and the European League Against
Rheumatism (EULAR) has promoted basic, intermediate, and advanced ultrasound
courses in addition to a number of projects under the auspices of the EULAR Working
Party on Musculoskeletal Imaging aimed at standardizing both ultrasound training and
practice.
High-resolution grey-scale ultrasonography improves our ability to detect tiny,
hidden erosions and minute amounts of fluid and soft tissue changes in synovial joints
at the earliest stages of disease. The resolution of grey-scale ultrasonography is now
under 300 µm producing one of the highest levels of definition of musculoskeletal soft
tissue morphology. (61) In combination with real-time imaging advances in colour
and power Doppler imaging may allow functional depiction and assessment of
inflamed joints and vasculitides. Initially, power Doppler was considered far more
superior in sensitivity with respect to  the  detection  of  slow  flow  in  soft  tissues  and
also promised fewer artifacts, than the forerunner, colour Doppler.
Power Doppler Imaging (PDI) is a promising new sonographic technique for
evaluating the vascular system. PDI uses special processing to display the amplitude
or strength of the Doppler signal, rather than velocity and directional information as in
conventional color Doppler. This allows a much greater sensitivity in detecting small
vessels and slow-moving blood. (62 - 64) Its increased flow sensitivity and better
vascular delineation have been used to document the presence and characteristics of
flow in vessels that are poorly imaged with conventional color Doppler (CD). (62- 64)
Unlu et al present some interesting data on the role of color and duplex Doppler
ultrasound in detecting SI and spinal inflammation. (65).
Ultrasonography has proved a highly sensitive, noninvasive, and practical tool
in assessment of bone and joint pathology, and is gaining increasing attention in many
different areas of rheumatology practice. Within  the  area  of  SpA,  Doppler
ultrasonography is currently being used to detect enthesitis and to assess response of
enthesitis to therapy. (66).
The presence or absence of sacroiliitis as detected by whatever reliable,
reproducible, and affordable method will continue to be a cornerstone for earlier
diagnosis of AS. Potentially, Doppler ultrasonography, due to its relative availability
and low cost, may be a useful tool in diagnosing patients with AS and assessing
response to therapy. Further work is definitely warranted in this area.
Understanding the fundamentals of Ultrasound Imaging
Having a strong grasp of pattern recognition is essential when it comes to
interpreting MSU images. All tendons, nerves, muscles and bone have a characteristic
quality on MSU imaging. Tendons have a fibrillar pattern or appear as densely packed
bright white lines on a dark background. The best example is the Achilles tendon.
Nerves have a fascicular pattern. For example, with the median nerve, clinicians will
note bright whites lines that are not densely packed on a black background. One can
compare a MSU image of muscle to a feather with characteristic bright white lines
emanating  from  the  septa.  However,  Power  Doppler  is  an  excellent  technique  for  a
quick evaluation of cortical surface but it cannot useful for imaging of internal
cortical pathology. Clinicians can easily identify bone by its bright echo-texture and it
is usually the deepest or lower image one sees on the screen.
It is imperative to have a grasp of what ultrasound is before one can truly
appreciate the technology. Simply, ultrasound waves are mechanical sound waves
above the hearing frequency of the human ear. Humans hear frequencies between 20
Hz to 20,000 Hz. Sounds below 20 Hz, which can only be heard by animals, are
called infrasound. Ultrasound refers to sounds above 20,000 Hz.
Principles and applications
Today, we have diagnostic ultrasound machines capable of hearing up to 18
MHz’s. The images are generated by a transducer and a synthetic piezoelectric crystal
that vibrates under electric currents. The ultrasound pulses travel through tissues and
are reflected at interfaces or boundaries in which tissues with different acoustic
properties meet. For example, fluid and bone have different acoustic properties, and
one  can  easily  distinguish  these  under  ultrasound.  Bone  will  appear  bright  white
(hyperechoic) and fluid black (hypoechoic). The echoes that return traverse the
piezoelectric crystal and create electrical potentials to grey-scale imaging. This leads
to the grey and black images we see on the ultrasound monitor. To help detect blood
flow  and  direction,  we  use  color  Doppler  ultrasound.  However,  when  it  comes  to
MSU, we are more interested in power Doppler ultrasound, which aids in detecting
low blood flow states in conditions such as synovitis.(65- 68).
The terminology is equally important. The reflected sound waves are either
hypoechoic, hyperechoic and anechoic. Anechoic sound waves are structures without
internal reflectors.  No echoes are returned with these sound waves so clinicians will
see black areas of the image (i.e. cartilage, effusions). Hypoechoic sound waves
involve structures with low-level echoes that produce weaker reflections or darker
grey areas of the image (i.e. muscle, synovial tissue, peripheral nerves). Hyperechoic
sound waves are structures with high level echoes that produce bright grey reflections
of the image (i.e. bone, calcifications, tendons, foreign bodies.
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Spondyloarthritis is a chronic inflammatory disease that primarily involves the
axial skeleton. The current standard imaging method in SpA/ AS is sacroiliac (SI) and
spinal conventional plain radiography. Radiography reveals the consequences of
inflammation, but cannot detect active inflammatory lesions when used alone (63, 64
and 69). CT- SCAN can detect the end result of inflammation like erosions, sclerosis
but acute and active inflammation like marrow edema cannot be made out accurately.
(57, 58, 69) However CT imaging requires a large radiation dose, (15-20 mGy per
examination) to the gonads in particular for patients who are young. However
dynamic CT and contrast CT identify active inflammation by additional burden of
higher cost (57).
Magnetic resonance imaging (MRI), on the other hand, can detect SI and
spinal, active inflammatory lesions. (55, 71) Nevertheless, MRI is a relatively
expensive and time-consuming method by its own technique and by number joints to
be imaged: Hence its routine use in every patient would be difficult in daily practice.
Another factor that limits usage of MRI is that an important proportion of AS patients
have prostheses. Therefore, an easier and cheaper method is needed to detect the
degree of spinal inflammation.
A Closer look at Musculoskeletal Ultrasound
Richard H. Haddad et al offered pertinent pointers about the adjunctive
potential of musculoskeletal ultrasound in diagnosing common arthritic conditions
ranging from rheumatoid arthritis, Spondyloarthritis to crystal-induced
arthropathies. (72).
Musculoskeletal ultrasound (MSU) is an excellent technique for evaluating
soft tissue and cortical involvement in rheumatic diseases. Over the past few years,
rheumatology health care professionals have demonstrated an exponentially growing
interest in MSU due to its diagnostic potential. (65 – 68, 72) Indeed; ultrasound
provides an adjunctive tool in the assessment of many of the common entities (i.e.
shoulder pain, swollen joints) that clinicians encounter in daily practice. In
comparison to other imaging modalities, ultrasound is the only imaging tool clinicians
can use at the bedside and they can also use the modality to assist with joint
injections. The main advantages of MSU are dynamic real-time scanning, absence of
radiation, many number of joints can be seen on the same day, low cost, exact
localization of symptoms and most importantly, patient acceptance and of course,
diagnosis reached on the same day. To aid in diagnosis, the sonographer performing
the scan can correlate the clinical findings with the ultrasound images and
immediately compare with the contralateral side. Therefore now power Doppler is
considered as a rheumatologist’s extended arm but more appropriately, it’s a
rheumatologist’s stethoscope and also being called as poor man’s MRI.
With the advancing technology over the years, ultrasound has evolved to a
point where it allows exquisite visualizations of anatomy without invasive procedures.
Musculoskeletal ultrasound has proven to be valuable in diagnosing common
rheumatological conditions including rheumatoid arthritis, crystal-induced arthritis,
seronegative spondyloarthropathies and osteoarthritis.
A standard approach is important. First, the technique is an art and having a
solid knowledge of anatomy is essential for MSU. Secondly, like learning any other
technique, practice is essential. Thirdly, one must learn the limitations of ultrasound.
For example, ultrasound has not been useful for imaging internal cortical pathology.
Fourthly, to avoid blooming artifacts we would need to adjust Doppler gain to an
unacceptably low level, which would lead to non-visualization of true flow. Another
alternative to minimizing blooming artifact is to increase the Doppler frequency.
Moreover 3 RI measurements per vessel are recommended and the median value
should be taken-(normal RI 1-1.5). (60, 72).
Therefore, clinicians should consider ultrasound as a complementary modality
to magnetic resonance imaging (MRI) and conventional radiography in daily practice.
The Challenge of Early Diagnosis in Ankylosing Spondylitis
Until recently, treatment options for AS were limited. Conventional disease-
modifying anti rheumatic drugs, which are effective in other chronic inflammatory
diseases such as rheumatoid arthritis, have only a very limited effect on spinal
inflammation. Thus, while an early diagnosis has been recognized as important in
these patients, this seemed less urgent for many physicians because of the lack of
therapeutic options.
This treatment approach has now changed. Non steroidal antiinflammatory
drugs, the mainstay of treatment for control of symptoms, may have a protective
effect on structural damage when taken on a regular basis. Anti-tumor necrosis factor
(TNF) agents offer an exciting new possibility for effective treatment and possibly
arrests disease progression. It has been shown that the anti-TNF agents have a prompt
and robust effect on almost all aspects of active disease —most notably not only pain
or fatigue, but also function, spinal mobility, peripheral arthritis, enthesitis, bone
density, and acute inflammation as reflected by acute phase reactants and magnetic
resonance  imaging  (MRI).  It  has  also  been  shown  that  AS  patients  with  shorter
disease duration are more likely to respond to anti-TNF agents than patients with
longstanding disease. (56, 73- 75).
There are a number of reasons for the long delay in the diagnosis of AS. First,
the established classification criteria for AS, which date back over 20 years, rely on
the combination of clinical symptoms plus unequivocal radiographic sacroiliitis of at
least grade 2 bilaterally or grade 3 unilaterally. The radiographs are often normal
when symptoms arise and it usually takes several years for definite radiographic
sacroiliitis to evolve. (75, 76) Secondly, there is no pathognomonic clinical feature or
laboratory test to make the diagnosis of AS. It is a challenge to attempt to identify the
estimated 5% of chronic low back pain that represents AS. In this regard, AS presents
a distinct diagnostic problem since it occurs in the context of a highly prevalent
condition —low back pain —in which it represents a small subset.(77) This is not true
for polyarthritis, in which rheumatoid arthritis represents a large subset.
Choosing clinical characteristics for screening patients for underlying AS is
attractive because their determination is not expensive. The clinical symptom of
inflammatory back pain (IBP) has been recognized as a cardinal symptom for AS for
years, and assessment requires neither laboratory tests nor radiographic studies. It has
been estimated that when symptoms of IBP are present in a patient with chronic low
back pain, the post-test probability for this patient having the diagnosis of axial SpA
is 14%. Recent refinement of these clinical features has identified a candidate core set
of criteria for IBP: (1) morning stiffness of > 30 minutes, (2) improvement in back
pain with exercise but not with rest, (3) awakening because of back pain during the
second half of the night only, and (4) alternating buttock pain. (76, 77 and 78)  These
features were defined by a study that sought to identify the most sensitive and specific
combination of characteristics for IBP using a cohort of patients with established
diagnosis of AS and mechanical back pain. If at least 2 of these 4 characteristics were
fulfilled, this yielded a sensitivity of 70% and a specificity of 81%, with a positive
likelihood ratio of 3.7 for AS. If  at  least  3 of the 4 characteristics were fulfilled,  the
positive likelihood ratio increased to 12.4. How these discriminating features perform
in a large population with nonspecific back pain remains to be examined.
Currently, imaging is essential for the diagnosis of AS for the purpose of
identifying the presence of sacroiliitis. Although plain radiography is always the
initial method for evaluating the SI joints, its accuracy is limited by the lack of
sensitivity in early stages of the inflammation and by high intra- and interobserver
variability in interpretation. The grade of sacroiliitis is critical for the diagnosis of AS,
and plain radiographs of the SI joints are divided into 4 grades, from normal to fully
ankylosed. Differentiation of grade 1 (suspicious change) and grade 2 (minimal
abnormality —small localized areas with erosions or sclerosis without alteration in
joint width) is where most of the diagnostic variability arises. In these cases, different
imaging techniques might be helpful. (79). Quantitative SI joint scintigraphy,
computed tomography (CT), and MRI are the currently available imaging modalities
to evaluate sacroiliitis. Despite the use of these different modalities, difficulties in
diagnosing sacroiliitis remain. By using CT, sclerosis and ankylosis can easily be
diagnosed,  and  for  the  detection  of  bony  changes,  CT  can  be  superior  to  MRI.
However, MRI also identifies abnormalities thought to reflect inflammatory disease
activity in the joint and subchondral bone. (80) The sensitivity of quantitative SI joint
scintigraphy is reportedly high, but the increased bone turnover in SI joints lowers the
specificity of this technique. (81).
MRI has been proposed by many investigators as the best method of detecting
sacroiliitis, especially early in the course of the disease. It can demonstrate early pre
destructive alterations of sacroiliitis. However, the availability of MRI is often limited
and the technique is time-consuming and costly, imposing practical difficulties for its
clinical application in all patients with inflammatory back pain and suspected
sacroiliitis. MRI is also limited in patients with metal implants or pacemakers, or with
claustrophobia.
Where exactly MRI fits in our diagnostic armamentarium is not yet fully
resolved. It has recently been shown that conventional radiography can detect
structural  changes  in  the  SI  joint  with  greater  sensitivity  than  MRI.  (59)  However,
inflammation  on  MRI can  be  found in  a  substantial  proportion  of  patients  with  IBP
but with normal radiographs. Applying only MRI (even if this were practical in the
real world) might underestimate structural changes of sacroiliitis. Recent studies have
suggested that assessment of structural changes, first by conventional radiography
followed by assessment of inflammation on MRI in patients with negative
radiographic studies, yields the highest probability of detecting involvement of the SI
joints in patients with recent onset IBP, and same can appreciated by Power
Dopplerultrasound.
Power Doppler Ultrasound Imaging (PDUS)
Ercument Unlu et al (65, 72) valued that ultrasonography has proved a highly
sensitive, noninvasive, and practical tool in assessment of bone and joint pathology,
and is gaining increasing attention in many different areas of rheumatology practice.
Within the area of SpA, Doppler ultrasonography is currently being used to detect
enthesitis and sacroiliitis and to assess response of enthesitis to therapy. (62, 82).
The presence or absence of sacroiliitis as detected by whatever reliable,
reproducible, and affordable method will continue to be a cornerstone for earlier
diagnosis  of  AS.  Potentially,  Power  Doppler  ultrasonography,  due  to  its  relative
availability and low cost, may be a useful tool in diagnosing patients with AS and
assessing response to therapy. Further work is definitely warranted in this area.
Understanding  the  fundamentals  of  Ultrasound  Imaging
Having a strong grasp of pattern recognition is essential when it comes to
interpreting MSU images. All tendons, nerves, muscles and bone have a characteristic
quality on MSU imaging. Tendons have a fibrillar pattern or appear as densely packed
bright white lines on a dark background. The best example is the Achilles tendon.
Nerves have a fascicular pattern. For example, with the median nerve, clinicians will
note bright whites lines that are not densely packed on a black background. One can
compare a MSU image of muscle to a feather with characteristic bright white lines
emanating from the septa. However ultrasound has not been useful for imaging of
internal cortical pathology. Although, it is an excellent technique for a quick
evaluation of cortical surface. Clinicians can easily identify bone by its bright echo-
texture  and  it  is  usually  the  deepest  or  lower  image  one  sees  on  the  screen.  It  is
imperative to have a grasp of what ultrasound is before one can truly appreciate the
technology. Ultrasound waves are mechanical sound waves above the hearing
frequency of the human ear. Humans hear frequencies between 20 Hz to 20,000 Hz.
Sounds below 20 Hz, which can only be heard by animals, are called infrasound.
Ultrasound refers to sounds above 20,000 Hz. Today, we have diagnostic ultrasound
machines capable of hearing up to 18 MHz’s. The images are generated by a
transducer and a synthetic piezoelectric crystal that vibrates under electric currents.
The ultrasound pulses travel through tissues and are reflected at interfaces or
boundaries in which tissues with different acoustic properties meet. For example,
fluid and bone have different acoustic properties, and one can easily distinguish these
under ultrasound. Bone will appear bright white (hyperechoic) and fluid black
(hypoechoic). The echoes that return traverse the piezoelectric crystal and create
electrical potentials to grey-scale imaging. This leads to the grey and black images we
see on the ultrasound monitor. To help detect blood flow and direction, we use color
Doppler ultrasound. However, when it comes to MSU, we are more interested in
power Doppler ultrasound, which aids in detecting low blood flow states in conditions
such as synovitis.
The terminology is equally important. The reflected sound waves are either
hypoechoic, hyperechoic and anechoic. Anechoic sound waves are structures without
internal reflectors.  No echoes are returned with these sound waves so clinicians will
see black areas of the image (i.e. cartilage, effusions). Hypoechoic sound waves
involve structures with low-level echoes that produce weaker reflections or darker
grey areas of the image (i.e. muscle, synovial tissue, peripheral nerves). Hyperechoic
sound waves are structures with high level echoes that produce bright grey reflections
of the image (i.e. bone, calcifications, tendons, foreign bodies).
Spondyloarthropathies:
Can MSU Aid In The Diagnosis?
The family of spondyloarthropathies is characterized by a number of
overlapping features and inflammation at the insertion of tendons to bone, which is
referred to as enthesitis. Clinicians can usually detect peripheral enthesitis by clinical
examination; there is a lack of specificity when it comes to generalized pain, swelling
and tenderness. The characteristic radiographic diagnosis of sacroiliitis is relatively
late. Recently, clinicians have recognized MSU as a sensitive technique to assess
tendon or ligament involvement. Researchers have reported using power Doppler to
detect inflammation and low blood flow within the tendon, which is a sensitive
indication for tendinitis. Clinicians have also described enthesitis in psoriatic arthritis.
In clinical practice, it can be challenging to diagnose patients who present with
generalized arthralgias and without psoriasis. In lower limbs, the most common sites
of entheseal involvement are the knee and heel where the Achilles attaches to the
calcaneus. For example, one patient was initially diagnosed with osteoarthritis of the
knee. After author used MSU, able to diagnose psoriatic arthritis based upon the
sonographic findings of his Achilles.
US Imaging in SpA and role of three dimensional imaging.
Recent review in Current Opinion Rheumatology by Kelly, Stephen A et al
opined that ultrasound has developed significantly over the past decade, becoming a
potent imaging modality for the assessment of inflammatory arthritis. Ultrasound
imaging has been shown to be more sensitive than clinical examination in detecting
many features of spondyloarthritis, such as synovitis and enthesitis. The ability to
detect subclinical disease and demonstrate a clear response to therapeutic intervention
makes this imaging modality a potential tool for both diagnostic and monitoring
purposes. Despite this, a number of issues including a lack of standardization of
ultrasound assessment of musculoskeletal disorders continue to hamper its progress.
New three-dimensional technology is a promising development, which may allow this
problem to be addressed.  Improving the ability of the rheumatologist to predict
prognosis and guide therapeutic intervention is a long-term goal, to which ultrasound
may be able to provide a significant contribution. The addition of a novel imaging
modality to currently available assessment tools may provide rheumatologists with a
more precise working framework, which may be exploited for the benefits of the
patients.
Colour and Duplex Doppler Sonography to Detect Sacroiliitis
and Spinal Inflammation in Ankylosing Spondylitis.
Ercüment Unlü et al has demonstrated that signs of active sacroiliitis can be
detected by the colour and duplex Doppler ultrasonographic (CDDUS) method, and
that antiinflammatory therapy would lead to improvement in signs of active
sacroiliitis.(65).
Klauser A et al in another study, the value of contrast-enhanced colour
Doppler ultrasound and MRI were compared in diagnosing SI inflammation and it
was shown that ultrasound had a high negative predictive value in the detection of
inflamed SI joints (83) In this study, determined the degree of SI and spinal
inflammation in AS patients was determined by CDDUS, and their relationship with
clinical activity variables was evaluated in addition to, detecting changes following
anti-TNF therapy. CDDUS detected arterial vascularity for measurement within or
around SI joints and in paraspinal areas in all AS patients, including controls. In the
AS  group,  mean  RI  values  of  SI  joints,  LV,  and  TV  areas  were  significantly  lower
than in controls (p = 0.003, 0.004, and 0.01, respectively). In patients with AS who
had active disease according to BASDAI score, the ratio of men was higher (p =
0.034), and higher values were recorded for mean ESR (p = 0.05) and CRP (p <
0.001).
In their study, AS patients had significantly lower RI values of SI joints and of
LV and TV areas when compared to controls. It was suggested that proangiogenic
factors lead to increased vascularization in regions of prominent inflammation such as
SI joints, which could be associated with disease activity in patients with AS. As a
result, RI value is expected to be lower in patients with active inflammation because
of hypervascularization.
In the CDDUS study by Arslan, et al (82), RI was similarly significantly
decreased in patients with active sacroiliitis, and then increased after
antiinflammatory therapy. However, the study group was heterogenous as against
Ercüment Unlü et al study because they used patients with tuberculosis and psoriatic
arthritis.
Recently, Klauser, et al (65) reported that, compared with MRI, microbubble
contrast-enhanced color Doppler US was a sensitive technique with high negative
predictive value for detection of active sacroiliitis. However, their study considered
vascularization  within  the  SI  joints  but  not  the  areas  around the  joints.  Arslan,  et  al
and Ercüment Unlü, et al studied the vascularization around SI joints was examined
and measurements were made in all patients. Moreover, the purpose of the study by
Klauser, et al was to test the diagnostic usefulness of Doppler US in inflammatory
back pain, included 103 patients with inflammatory back pain, 75% of whom turned
out to have some form of spondyloarthropathy. The study was also different in that it
did not include data such as clinical activity parameters and changes after anti-TNF
therapy. Neither of the 2 studies evaluated LV and TV. Whereas Arslan, et al was the
first study to evaluate LV and TV by CDDUS.
In  the  study  by  Arslan,  et  al,  it  was  demonstrated  that  SI  joint  RI  increased
after antiinflammatory therapy and reached levels similar to those in the control
group. Thus, CDDUS was shown to be useful to demonstrate degree of SI and spinal
inflammation as well as regression of inflammatory signs after anti-TNF therapy.
The limitations of this study were that, evaluations was performed by only one
radiologist, and no comparison with a more standard method like MRI was made. In
addition, it was a disadvantage that no previous data was available on vascularization
around LV and TV regions. However, RI values in these areas were lower in patients
than in controls and in the active group versus the inactive group; there was also a
significant increase in LV RI after anti-TNF therapy. Together, these findings prove
that our methods were correct.
They conclude that CDDUS method might be useful to detect degree of
inflammation in SI joints and in LV and TV paraspinal areas in patients with AS. In
patients with active disease, a low RI may indicate increased inflammation (RI< 1.5).
When evaluating early response to anti-TNF therapy in patients with active disease,
CDDUS might be an alternative to MRI because it is inexpensive, easy, can be
performed at the bedside, and is less time-consuming. Rather than as a method used
for diagnosis, CDDUS might be more suitable to detect disease activity and to obtain
more quantitative data about response to therapy. Ours is the first study using CDDUS
to evaluate LV and TV vascularization and to interpret response to anti-TNF therapy
in light of clinical characteristics. This method merits further study to develop and
standardize this use of CDDUS.
The study  by Bredella MA et al (85) was to evaluate whether MRI findings of
the sacroiliac joints are able to distinguish between active and inactive disease in
patients with established ankylosing spondylitis and to determine whether these
findings correlate with markers of clinical activity, disease duration, severity, and
degree of radiographic damage on eighteen patients with symptomatic moderate to
severe ankylosing spondylitis were evaluated. MRI of the sacroiliac joint (1.5 T) was
performed using fat-saturated T2-weighted, T1-weighted, STIR, and fat-saturated
contrast-enhanced T1-weighted sequences. The sacroiliac joints were evaluated by
two radiologists for enhancement, subchondral bone marrow edema, erosions, and
subchondral fatty marrow infiltration. Findings on MRI were analyzed for correlation
with multiple clinical characteristics and measures of disease activity, including
radiographic scoring. MRI showed abnormal findings of the sacroiliac joint in 17
patients. Ten patients showed active disease on MRI as measured by abnormal
enhancement and subchondral bone marrow edema. Disease activity detected using
MRI correlated in a positive fashion with only C-reactive protein (CRP) level. There
was no correlation with the other measures of disease activity or with disease
duration. In 14 patients, fatty subchondral bone marrow was detected on MRI. These
changes were seen in patients with active and chronic disease and correlated with
higher radiographic scores but not with disease duration or markers of disease
activity. Contrast-enhanced MRI of the sacroiliac joint is sensitive in depicting
sacroiliitis in patients with established ankylosing spondylitis. Subchondral edema
and enhancement correlated with high CRP levels. Subchondral fatty bone marrow
changes were seen in both active and chronic sacroiliitis and correlated with higher
radiographic scores. These changes may be a marker of more advanced disease.
Vogler et al (87) evaluated the CT appearances of sacroiliac joints in
asymptomatic patients, to define the normal joint appearances and differentiate it from
early CT signs of sacroiliitis. In their study, they correlated findings in asymptomatic
and sacroiliitis groups, and categorized them into two groups. CT findings that were
grouped as poor CT indicators of sacroiliitis, by virtue of its frequent occurrence in
the asymptomatic population included non uniform iliac sclerosis (83%), focal joint
space narrowing in patients over the age of 30 (74%), and ill defined areas of
subchondral sclerosis, particularly on the iliac side (67%). Conversely, the good CT
indicators of sacroiliitis were those that occurred infrequently in the asymptomatic
population, and comprised increased sacral subchondral sclerosis in subjects under the
age of 40 (11%), bilateral or unilateral uniform joint space of less than 2 mm (2% or
0%, respectively) and erosions (2%) .
The value of MRI in the diagnosis of sacroiliitis has been well established.
MRI accurately delineates the cardinal features of sacroiliitis, like changes in joint
space width and symmetry, presence of erosions, subchondral edema, sclerosis, cysts
and ankylosis. Furthermore, MRI plays a useful role in patients with early disease, by
its superior ability to directly image changes in articular cartilage. Comparative
studies between MRI and CT in the evaluation of patients with suspected sacroiliitis
have further shown that the sensitivity and specificity of MR for the detection of
cortical erosions and subchondral sclerosis when compared to CT images were 100
and 94.3%, respectively. MRI offers valuable information on the lesions affecting the
various structures of the sacroiliac joint in sacroiliitis.
Wanders A (86) and Finbar o'shea et al (88) in their study of the challenge of
early diagnosis in ankylosing spondylitis has now changed. Non steroidal
antiinflammatory drugs, the mainstay of treatment for control of symptoms, may have
a protective effect on structural damage when taken on a regular basis (86). Anti-
tumor necrosis factor (TNF) agents offer an exciting new possibility for effective
treatment and possibly arrest of disease progression. It has been shown that the anti-
TNF agents have a prompt and robust effect on almost all aspects of active disease —
most notably not only pain and fatigue, but also function, spinal mobility, peripheral
arthritis, enthesitis, bone density, and acute inflammation as reflected by acute phase
reactants and magnetic resonance imaging (MRI). It has also been shown that AS
patients with shorter disease duration are more likely to respond to anti-TNF agents
than patients with longstanding disease.
The Role of US in the Diagnosis of PsA
David Kane et al (89) have described in arthritis Rheumatism that psoriatic
arthritis (PsA) presents many diagnostic, management and research challenges for
rheumatologists who wish to obtain early diagnosis, differentiate synovitis and
enthesitis, monitor disease activity accurately and objectively, prevent the
development  of  structural  damage,  deliver  local  therapy  accurately,  and  obtain  PsA
tissue for research purposes. Musculoskeletal ultrasound (MSUS) is widely used by
European rheumatologists in their clinical practice to meet these challenges and has
the potential to become the rheumatologist’s stethoscope in Europe and North
America. This paper examines the evidence that MSUS can improve clinical
evaluation  of  patients  with  PsA  for  synovitis  and  enthesitis,  that  MSUS  is  more
sensitive than plain radiography in detecting structural damage in joints, that MSUS
can improve the success of joint aspiration and guide biopsy of PsA tissues. Recent
exciting developments in the management of PsA are detailed including the role of
power  Doppler  in  the  diagnosis  of  enthesitis  in  PsA,  the  role  of  MSUS in  objective
monitoring of disease activity, the evaluation of MSUS in the diagnosis of sacroiliitis,
and the use of MSUS to guide therapeutic injection of the sacroiliac joints.
Aim
AIM OF THE STUDY
1. Early diagnosis of SpA by imaging before radiological erosions.
2. To compare Power Doppler imaging of sacroiliitis with conventional
CT and MRI scan of Pelvis.
Objectives
OBJECTIVES OF THE STUDY
AS/SpA is a significant health burden. Symptoms of AS commonly begin in
late  adolescence  and  early  adulthood,  at  a  normal  productive  time  of  life.  If
undiagnosed or inadequately untreated, continuous pain, stiffness, and fatigue are the
consequences. Further, a potentially progressive loss of spinal mobility and function
result in a reduction in the quality of life.
In  the  context  of  all  the  inflammatory  rheumatic  diseases,  there  is  an
unacceptably long delay between the onset of symptoms and the time of diagnosis for
AS —an average interval of 8–11 years has been reported. The purpose of choosing
these patients for the study was, because they are the commonest diseases affecting
the young population during the earning period of their life and causing severe
morbidity.
Sacroiliitis is seen mostly in all patients of SpA and limits their mobility and
rapidly goes for ankylosis of these joints and permanently incapacitates them in their
day to day activities including sexual life.
Added to that, sacroiliac joint inflammation can be a difficult problem to
diagnose for a few reasons: The SI joint is not easily palpated or manipulated and
Studies (X-Rays, MRIs, CAT Scans, Bone Scans) are often normal- especially if the
radiologist is not clued in as to what to look for, therefore the early detection of
sacroiliitis in patients with SpA/ AS, and the early institution of appropriate
rheumatological treatments such as NSAID, (Non steroidal anti inflammatory drugs)
DMARD, (Disease modifying anti –Rheumatoid drugs) THE BIOLOGICALS (TNF
alpha inhibitors) with EARLY INITIATION OF PHYSIOTHERAPY can restore near
normal life.
Here again, the most important aspects to note are that x-rays of pelvic joints
are unable to pick up the early synovial inflammation and erosions, hence the early
diagnosis of sacroiliitis wholly depends on the MRI-SCAN and CT-SCAN,  which are
expensive.
Recently the power colour Doppler ultrasound in the field of Rheumatology
armamentarium is considered  as the extended hands of Rheumatologist’s and also
declared as the “ poor man’s MRI SCAN ” in early diagnosis of synovitis/ enthesitis/
tenosynovitis/ synovial effusions and proliferation / erosions of cartilage/ bone /joint
margin / endochondral bone erosion and cyst / osteopenia and crystal deposition
diseases.
This study aimed to compare and evaluate the validity and its clinical
usefulness of the power Doppler ultrasound with most commonly done CT-scan and
MRI scan in early diagnosis of sacroiliitis in patients with Spondyloarthropathies.
Materials
and
Methods
MATERIALS AND METHODS
In this prospective case control study from January 2007 to February 2009,
one hundred and eight patients (84 males, 24 females) were included from those who
had presented with signs and symptoms and clinical features of Spondyloarthropathies
to the Department of Rheumatology, Madras Medical College and Govt. General
Hospital, Chennai. 3. 35 age and sex matched asymptomatic controls were selected
from patient’s attender’s who were not I? or II? relatives of the patients and were
included as the controls for Power Doppler US of the sacroiliac joints.
Inclusion Criteria
Age of onset of disease from16 years to 40 years and
Patient’s with
Ankylosing spondylitis
Reactive arthritis
Psoriatic arthritis
IBD associated arthritis
Undifferentiated spondyloarthritis
Exclusion Criteria
Age of onset of disease < 16 years and  > 40 years
Pregnant females
Diseases mimicking as AS- such as
Flourosis of spine
Diffuse idiopathic skeletal hyperostosis (DISH)
Degenerative spinal diseases (spondylosis deformans)
Methods
All patients were asked for a detailed history which includes the age of onset
of  disease,  symptoms  of  disease,  duration  of  the  disease  and  relevant  symptoms  of
secondary AS. A detailed general examination, height and weight were done.
The musculoskeletal examination and including axial joints and SIJ and other
systems examination  was  done.  Disease  activity  indices  like  ESR,  CRP levels  were
determined. Detailed Bath AS Disease Activity Index (BASDAI) scores were
calculated. In addition, chest expansion, finger-to-floor distance, occiput-to-wall
distance, tragus-to-wall distance, modified Schober (mSchober), lateral spinal flexion,
cervical rotation and intermalleolar distance were measured; and Bath AS Metrology
Index (BASMI) was calculated using cervical rotation, tragus-to-wall distance, lateral
spinal flexion, mSchober, and intermalleolar distance.
Peculiarities of SIJ
Sacroiliac joint is a unique joint in the human body with differences in type
and thickness of articular cartilage between different regions of the sacral and iliac
articular surfaces. (4, 44, 45) Light microscopy and immunohistochemistry has shown
significant differences between the iliac and sacral articular cartilages as described in
a recent study by Kampen. The sacral cartilage is thick, has low cell density, and rests
upon a thin bone end-plate supported by porous, cancellous bone. In comparison, the
iliac cartilage is thin, has high cell density, resting on thicker subchondral bone end-
plates, supported by twice as dense subchondral cancellous bone. The thickness at
sacral side and iliac side in adults is 4 mm and 1-2 mm respectively. The spongiosa
trabeculae at sacral subchondral bone are inserted at right angles, implying a
perpendicular load on the articular facet, unlike the iliac side where there is no
definite alignment of subchondral spongiosa. Moreover, blood vessels penetrate
subchondral bone plate at both the iliac and sacral surfaces, coursing closely on the
overlying articular cartilage, which causes the high incidence of inflammatory
diseases at sacroiliac joint.
Technique of power Doppler  examination
First subjects were in the prone position during examination. In order to detect
SI joints, the transducer was moved in a transverse direction 3–4 cm to the right and
left  of  the  sacral  spinous  processes  in  the  gray-scale  US  mode;  measurements  were
performed from the posterior point of the cleft-shaped SI joint that was closest to the
transducer. Secondly, US evaluation is performed with the patient in the prone
position, starting with a grey-scale US examination to identify the bony spinous
processes in the midline and the posterior part of the SI joints as the hypoechoic cleft
and to proceed to examine on both sides. Thirdly with the probe in transverse
position, the posterior contour of the sacrum is visualized as an echogenic line, while
the sacral spinous process is shown as a concave curve at the midline, with sacral
wings, represented by a regular echogenic line laterally. The SI joint is visualized as a
hypoechoic cleft between two echogenic lines (sacrum and iliac bone). If possible,
care was taken to perform the measurement from the arterial structure within the SI
joint. When no arterial recording could be obtained from inside the joint,
measurements were taken from the arterial structure closest to the joint.
When performing Power Doppler ( performed in two different centres with
GE Volusom 4D Experta, USA and with Siemens Acuson Antares, Aloka P 3500), a
12.5-MHz, high-resolution linear transducer was used in subjects with a skin-
subcutaneous fat tissue thickness < 3 cm, and a 3.5 MHz, high-resolution convex
transducer was used in subjects with skin-subcutaneous fat tissue thickness > 3 cm.
For CDDUS, the color box was focused on the area being examined. Standardized
machine settings that were applied included color Doppler gain 60–120 dB, wall filter
51–65 Hz, and pulse repetition frequency 300–850 Hz.). Resistive index (RI) [peak
systolic velocity – end-diastolic velocity / peak systolic velocity] values obtained
from CDDUS performed in SI and are calculated by the program loaded on the
machine. Measurements in each examination area were repeated 3 times, mean values
of those measurements were used for evaluation, and the results were recorded. In
each case CDDUS was completed in about 25–30 minutes. All patients were
evaluated by two radiologist, who were experienced in MSK ultrasound, at two
different centres and they were unaware of the subjects' clinical and laboratory data
(both patients and controls). To prevent variability in measurements, examination in
all subjects was performed by the same radiologist.
MRI  Pelvis/  SIJ  performed  with  (GE  Sigma  H  Dx-  3  Tesla  MRI,  USA  and
with Siemens 1.5 Tesla, Magnetic Symphony) T1FSE, T2FSE FATSAT by STIR in
axial, oblique and coronal planes. CT was done by Toshiba Asteion, Super 4, 120 KB,
and 400 MA.
Conventional radiographs of the pelvis were available in all patients. Chronic changes
in one SI joint were scored between 0 and 4 on the basis of the modified New York
criteria and the total chronicity score for both SI joints varied between 0 and 8.
Results
RESULTS
Demographic data
One hundred and eight patients were recruited in this study. Among these, 84
were males and 24 were females (3.5:1). The mean age of patients was 30  11.10
years (range from 16 to 59 years). The average disease duration was 3.46  5.23
years (range from one month to 23 years). There were 35 age and sex matched
controls (27 males, 8 females, mean age 30 ± 11). figure -1.
Categories of patients with Spondyloarthropathies
Undifferentiated  spondyloarthritis  was  seen  in  59  cases,  of  which  45  were
males and 14 were females. Among 31 cases of Ankylosing spondylitis, 28 were
males and 3 were females.12 cases of Reactive arthritis were found during this study,
among which, 8 were males and 4 were females. Only six cases of Psoriatic arthritis
were encountered during this study, with equal sex distribution. No cases of IBD
related arthropathies were seen during this study. figure-2.
Figure-1
Figure-2
Imaging of study
CT – Scan
CT- Pelvis was done in all patients. Bilateral symmetrical sacroiliitis were
seen in 60 patients and asymmetrical bilateral sacroiliitis were noted in 11 patients.
Among these, 6 cases showed right more than left side and five cases presented with
left more than right side. Unilateral sacroiliitis was seen on the right side in 15 cases
and on the left side seen in 10 cases. 12 cases had normal CT- Pelvis. figure-3.
MRI- Pelvis
MRI Pelvis was done only in 65 cases, due to cost factor. Among these, 43
were found to have bilateral symmetrical sacroiliitis and 6 cases had asymmetrical
bilateral sacroiliitis. Right sided sacroiliitis in 8 and left sided in 7 were observed.
Normal MRI was seen in one case. figure-4.
Power Doppler Ultrasound
Power Doppler US was done in all cases and with 35 age and sex matched
controls (27 males, 8 females, mean age 30 ± 11yrs). Bilateral colour flow with low
RI (Resistive Index) was seen in 67 cases. Asymmetrical colour flow with low RI was
seen in 12 cases. Right and left sided colour flow with low RI was seen in 13 and 4
cases respectively. No colour flow was seen in 12 cases and none in controls. Figure-
5& Figure-6.
Imaging of Reactive arthritis and Psoriatic arthritis
In this study, imaging of ReA and PsA, revealed bilateral sacroiliitis in 2 and
one case respectively. Unilateral sacroiliitis was noted in 10 cases in ReA and 5 cases
in PsA.  Figure-7.
Figure-7 and 9 are showing comparison of all three images.(all study cases
and statistically analyzed 65 cases respectively).
Figure-3
Figure-4
Figure-5
Figure-6
Figure-7
Figure. 8
Figure-9
Figure-10   (Control Patient)
Normal Power Doppler images (Lt. SIJ)
Figure-11.  Patient No. 105
Right SIJ showing echogenic cartilage and erosions
Figure-12 (Patient. No. 19)
Rt. SIJ showing joint space widening, iliac cartilage erosions and Doppler flow
Figure-13. (Patient No. 19)
Lt. SIJ showing joint space widening, echogenic
iliac cartilage and Doppler flow
Figure-14. (Patient No. 106)
Left SIJ showing Doppler flow with RI 0.81
Figure-15. (Patient No. 108)
Right SIJ showing Doppler flow with RI 0.62
Figure-16. (Patient No. 24)
Power Doppler showing inflammatory flow with RI=0.73
Figure-17. (Patient No.  21)
Power Doppler showing inflammatory flow with RI=1.00
Figure-18. (Patient No. 24)
Right SIJ showing Doppler flow with RI 0.62
Figure-19.  (Patient No. 14)
Left SIJ showing Doppler flow
Comparative figure- 20  (Patient No. 100)
Normal SIJ by CT scan
Normal SIJ by MRI scan
Inflammatory flow state on left side by Power Doppler US
Comparative figure-21 (Patient No. 47)
Normal SIJ by CT scan
MRI scan showing right side sacroiliitis, minimal
bone marrow edema and erosions
Doppler Inflammatory flow state on rihgt SIJ. No flow on Lt.side
Comparative figure-22  (Patient No. 22)
CT- Scan showing bilateral suspicious sacroiliitis
MRI showing bilateral sacroiliitis with erosions and bone marrow edema
Inflammatory flow present on both SIJ
Comparative figure- 23 (Patient No. 88)
Bilateral sacroiliitis by CT scan
Bilateral sacroiliitis by MRI scan with bone marrow edema and joint space narrowing
Doppler showing inflammatory flow on both sides
Comparative figure-24 (Patient No. 23)
Bilateral sacroillitis by CT-SCAN
MRI showing bilateral bone marrow edema, joint fluid inflammation and erosions
Doppler showing bilateral inflammatory flow state
Statistical analysis
Statistical  analysis  was  done  only  for  65  cases,  for  whom  all  three  imaging
studies was done. Among these, sacroiliitis was detected in 53 cases by imaging by
CT-scan, 64 cases by MRI- scan and 62 cases by Power Doppler Ultrasound.(Figure-
3,  4,  5  and  8)  In  this  study,  the  images  were  compared  as  follows,  CT  scan  versus
MRI (table-1), CT scan versus Power Doppler Ultrasound (table-2) and MRI scan
versus Power Doppler Ultrasound (table-3). Imaged patients were again, divided into
two groups. Group-1 with disease duration less than 1 year and Group-2 with disease
duration more than 1 year.
Table-1. Comparison of imaging by CT- scan versus MRI-scan
CT vs MRI scan All < 1 yr >1 yr
Both CT & MRI abnormal 53 23 30
CT abnormal & MRI normal 0 0 0
CT normal & MRI abnormal 11 9 2
Both normal 1 1 0
Total 65 33 32
Table-1 shows that CT- scan fails to detect sacroiliitis in 12 cases (10 in
group-1, 2 in group-2) whereas MRI scan was able to identify, sacroiliitis in 11 cases
(group-1) and misses to identify sacroiliitis in one case. (group-1).
Table-2. Comparison of imaging by CT- versus Power Doppler US
CT scan vs PD US All < 1 yr >1 yr
Both  CT & PD abnormal 50 23 27
CT abnormal & PD normal 3 0 3
CT normal & PD abnormal 12 10 2
Both normal 0 0 0
Total 65 33 32
Table-2. Shows that, CT- scan as in table-1, was unable pick up sacroiliitis in
12 cases (10 in group-1, 2 in group-2) whereas Power Doppler was normal (e.g. No
flow is detected) only in three cases.(group-2).
Table-3. Comparison of imaging of MRI scan with Power Doppler US
MRI vs Power Doppler All < 1 yr >1 yr
Both MRI & PD abnormal 61 32 29
MRI abnormal & PD normal 3 0 3
MRI normal & PD abnormal 1 1 0
Both normal 0 0 0
Total 65 33 32
Table-3 shows that, MRI scan was unable to demonstrate sacroiliitis in one
case and which was identified by the Power Doppler US. Whereas in group-2, Power
Doppler was unable to show the inflammatory flow in 3 cases, due to disease duration
more than 1 year.
Statistical analysis was done using CHI- SQUARE test, to see the validity of
imaging methods in spondyloarthritides and to identify the most useful imaging
methods, according to disease duration.
Table-4. Chi-square kappa statistics.
CHI-Square kappa statistics analysis for CT and MRI scan with Power Doppler US
                                       Validity and clinical agreement (%)
Images Sensitivity Specificity PPV NPV Accuracy ?
CT vs MRI 100 83 8 100 83 0.11
CT  vs PD 100 85 25 100 86 0.35
MRI  vs PD 100 95 25 100 95 0.38
PPV: positive predictive value; NPV: negative predictive value;  : kappa statistics.
Kappa statistics incorporation:
               0 -- 0.2   poor correlation
   0.2 – 0.4   fair correlation
   0.4 – 0.6   moderate correlation
   0.6 – 0.8   good correlation
         0.8 – 1.0   very good correlation
 In our study, statistical analysis  ?2, kappa (? ) statistics was done only for 65
cases for whom all three imaging investigations were done and with 35 controls.
(Controls  enrolled  only  for  Power  Doppler  US).  Statistically  when  CT-  scan  was
compared with MRI, the sensitivity of MRI was 100% and specificity 83%, positive
predictive value 8% (PPV), negative predictive value 100% (NPV), accuracy 83%
(Ac), kappa 0.11 (?), false positive rate 17% (FPR) and false negative rate 0% (FNR).
When CT scan was compared with Power Doppler US, the Power Doppler sensitivity
was 100% and specificity 85%, PPV25%, NPV100%, Ac 86%,   ?  0.35%, FPR 15%
and NPR 0%. When MRI was compared with Power Doppler US, the sensitivity was
100%, but specificity rises to 95%, PPV25%, NPV 100%, Ac 95%,  ?  8%, FPR 5%
and NPV was 0%. (vide chi-square table-4).
Statistically analyzed cases (65 cases) were again divided into two groups.
Group 1: Disease duration ? 1 year (33 cases) and group 2: > 1 year (32 cases) and
these two groups were again statistically analyzed and compared for MRI versus
Power Doppler US. In group: 1, both MRI and Power Doppler US was 100%
(sensitivity & specificity) whereas in group: 2, though MRI/ Power Doppler US was
100 % sensitive, the specificity decreases to 70%. (table- 1 to 3).
In  addition,  group:  1,  patients  and  their  3  images  were  statistically  analyzed
with OR (Odds Ratio). CT- scan OR 1.00, MRI- scan, OR 2.09 and Power Doppler
US, OR 2.20. Therefore, Power Doppler US was 2.20 times better than CT and MRI
scan in spondyloarthritis with disease duration less than 1 year.
The  following  tables-  5  to  7  are  presented  here  to  see  the  importance  of
imaging in ? 3 months but it was not analyzed statistically.
Table-5. CT SCAN vs MRI in disease duration <3 months
Both CT & MRI abnormal 7
CT abnormal & MRI normal 0
CT normal & MRI abnormal 3
Both normal 1
Total 11
Table-6. CT scan  vs  Power Doppler in disease duration< 3 months
Both CT & PD abnormal 7
CT abnormal & PD normal 0
CT normal & PD abnormal 4
Both normal 0
Total 11
Table-7. MRI vs Power Doppler in disease  duration < 3 months
Both MRI & PD abnormal 10
MRI abnormal & PD normal 0
MRI normal & PD abnormal 1
Both normal 0
Total 11
Table-8
Impact of duration of disease and the validity of imaging
    Normal in 108 cases
         ( all study cases)
     Normal in 65 cases
  ( statistically analyzed cases)
Duration of disease
&
Imaging
<3 mo 3mo-1yr >1yr <3 mo 3mo-1 yr >1 yr
CT- scan 3 9 0 3 9 0
MRI- scan 1 0 0 1 0 0
PD Ultrasound 0 0 12 0 0 3
Table-7 shows that, if the duration of the disease was less, the validity of imaging by
MRI and Power Doppler increased, whereas it was vice versa for the CT scan.
Likewise  Power  Doppler  US  also  ceased  to  be  useful  if  the  disease  duration  was
more.
Table -8.
ESR / CRP  and BASDAI analyzed with Student- t test
Duration < 1 yr >1 yr Analyzed value
Mean Mean t- test P-value Result
ESR 58.70 69.56 2.40 0.0183 *
CRP 13.84 19.11 2.87 0.005 **
BASDAI 4.74 3.74 5.50 0.0000 ***
In this study, acute phase reactants like, ESR and CRP were compared with
the disease durations like less than 1 year and more than one year. Mean ESR was
58.70 and 69.56 in group-1 and group-2 respectively. Range of ESR was 10 mm to
110 mm. Mean CRP was 13.84 and 19.11 in group-1 and group-2. Range of CRP was
from negative to 36. Both increased ESR and increased CRP were independently
statistically significant in group-1. ( P-0.01 & P-0.005).
Disease activity measure was done by BASDAI. The mean BASDAI was 4.74
and 3.74 in group-1 & 2 respectively. If BASDAI was more than 4.2, the disease
activities are more. BASDAI score was high in group-1 compared to group- 2, and it
was statistically significant. (P-0.0000).
Discussion
DISCUSSION
Across the world, spondyloarthritides is one of the most common connective
tissue diseases affecting males more than females in their late adolescence, early
adulthood, before the 4th decade’s and during the most crucial period of earning and
reproductive stage of life. The M: F sex ratio varies from 18.7:1 (27) to 2:1 (5, 6, 26,
and 27) in various published studies. In our study, the sex ratio was 3.5:1(males-84,
females-24). The mean age was 30 ± 11.10 years (range from 16 to 59 years). 35 (27
males, 8 females) age and sex matched controls were enrolled for Power Doppler
ultrasound (the mean age was 30 ± 11years and range from 16 to 54 years). The
average duration of the disease was 3.46 ± 5.23 years (range from 1 month to
23years). SpA results in a significant reduction in health and wreckage of quality of
life and leads to economic burden if not diagnosed early and or adequately treated.
In particular, in the early phase of AS, conventional sacroiliac radiographs
may be normal, and it has been proposed to diagnose the disease with predominantly
axial clinical manifestations before the presence of radiographic sacroiliitis. In
addition, earlier symptoms are often mild, ignored, or not recognized as being part of
SpA by the treating primary care physician. This ultimately results in complete
anatomical damage and radiological erosions, syndesmophytes formation and
ankylosis of the axial skeleton and sacroiliac joints. Although, different modalities of
imaging  investigations  like  CT,  MRI  SCAN  and  SCINTIGRAPHY  are  available  to
demonstrate the spinal inflammation and sacroiliitis, each one has its own merits and
demerits, hence other imaging modalities are being warranted in early diagnosis of
SpA.
By using CT scan, (57, 58) sclerosis, erosions and ankylosis can easily be
diagnosed, and for the detection of bony changes, CT scan is superior to MRI. In
addition, to cartilage erosions, MRI also identifies abnormalities, thought to reflect
inflammatory disease activity in the joint, cortical bone marrow and subchondral
bone. (51, 52) The sensitivity of quantitative SI joint scintigraphy is reportedly high,
but the increased bone turnover in SI joints lowers the specificity of this technique
(71, 81).
MRI has been proposed by many investigators as the best method of detecting
sacroiliitis, especially early in the course of the disease. Wittram Conrad et al (52)
did the comparative study of MRI and CT in suspected sacroiliitis in 39 cases with
9 controls. He found that, MRI (T1WFS and fast STIR) can replace CT in cases with
a strong clinical suspicion of sacroiliitis and equivocal or normal plain radiographs.
The sensitivity and specificity of MRI images for the detection of cortical erosions
and subchondral sclerosis when compared to CT images was 100 and 94.3%,
respectively. The interobserver variation was low (k = 0.80) with MR and T1WFS.
Fast STIR images were superior to T1 and T2 images. In our study, when CT scan
compared with MRI, the sensitivity of MRI was 100% and specificity 83% and CT
scan was unable to pick up sacroiliitis in 12 cases in group-1. In group- 2, both CT
scan and MRI have shown 94% sensitivity and specificity.
Another study by Battafarano DF et  al (90) by the Quantitative bone scan
(QBS), computed tomography (CT), and magnetic resonance imaging (MRI) have
each been used to confirm the diagnosis of active sacroiliitis (SI) in patients with low
back pain (LBP). The authors prospectively evaluated 19 patients referred for
symptoms of possible inflammatory LBP (group I), 26 seronegative
spondyloarthropathy (SNSP) patients with LBP (group II, inflammatory or
mechanical), and 5 SNSP patients without LBP (group III) to determine which
radiological scan was helpful in diagnosing Sacroiliitis.  He found MRI, which had
100% predictability, was the best single test for confirming active inflammatory SI. It
can demonstrate early predestructive alterations (bone marrow oedema) of sacroiliitis.
He also found that, ESR and CRP did not significantly correlate with sacroiliitis. (90)
In our study, as mentioned in previous paragraph, MRI had 100% predictability in
detecting active sacroiliitis. As against the Battafarano DF et al study, in ours, ESR
and CRP were statistically significant in disease duration less than 1 year (group-1),
P-0.01 & P-0.005 respectively.
The study  by Bredella MA et al (85)was to evaluate whether MRI findings of the
sacroiliac joints are able to distinguish between active and inactive disease in patients
with established ankylosing spondylitis and to determine whether these findings
correlate with markers of clinical activity, disease duration, severity, and degree of
radiographic damage on eighteen patients with symptomatic moderate to severe
ankylosing spondylitis. MRI of the sacroiliac joint (1.5 T) was performed using fat-
saturated T2-weighted, T1-weighted, STIR, and fat-saturated contrast-enhanced T1-
weighted sequences. The sacroiliac joints were evaluated by two radiologists for
enhancement, subchondral bone marrow edema, erosions, and subchondral fatty
marrow infiltration. Findings on MRI were analyzed for correlation with multiple
clinical characteristics and measures of disease activity, including radiographic
scoring. MRI showed abnormal findings of the sacroiliac joint in 17 patients. Ten
patients showed active disease on MRI as measured by abnormal enhancement and
subchondral bone marrow edema. Disease activity detected using MRI correlated in a
positive fashion with only C-reactive protein (CRP) level. There was no correlation
with  the  other  measures  of  disease  activity  or  with  disease  duration.  In  14  patients,
fatty subchondral bone marrow was detected on MRI. These changes were seen in
patients with active and chronic disease and correlated with higher radiographic
scores but not with disease duration or markers of disease activity. Contrast-enhanced
MRI of the sacroiliac joint is sensitive in depicting sacroiliitis in patients with
established ankylosing spondylitis. Subchondral edema and enhancement correlated
with high CRP levels. Subchondral fatty bone marrow changes were seen in both
active and chronic sacroiliitis and correlated with higher radiographic scores. These
changes may be a marker of more advanced disease. In our study, disease activity
was assessed by BASDAI, ESR and CRP, and were statistically significant in
group -1.  MRI in this group showed sub chondral - oedema  in 32 out of 33 patients
which reflects that more number of patients can be diagnosed in the early phase. But
we had not specifically observed for chronic fatty marrow changes in group 2 as
observed by Bredella MA et al.
Similar study by Finbar o’shea et al, observed that acute inflammation is
better reflected by MRI.(88).
The value of MRI in the diagnosis of sacroiliitis has been well established.
MRI accurately delineates the cardinal features of sacroiliitis, like changes in joint
space width and symmetry, presence of erosions, subchondral edema, sclerosis, cysts
and ankylosis. Furthermore, MRI plays a useful role in patients with early disease, by
its superior ability to directly image changes in articular cartilage. Comparative
studies between MRI and CT in the evaluation of patients with suspected sacroiliitis
have further shown that the sensitivity and specificity of MRI for the detection of
cortical erosions and subchondral sclerosis when compared to CT images was 100 and
94.3%, respectively.
Though, MRI was the major tool of imaging investigations in sacroiliitis, the
availability of MRI is often limited and the technique is time-consuming and costly,
imposing practical difficulties for its clinical application in all patients with
inflammatory back pain and suspected sacroiliitis. MRI is also limited in patients with
metal  implants  or  pacemakers,  or  with  claustrophobia.  Despite  the  use  of  all  these
different modalities, difficulties in diagnosing sacroiliitis remain.
Power Doppler US, has recently have taken a big stride in the field of
rheumatology, being called as “rheumatologist’s extended arm, rheumatologist’s
stethoscope and more appropriately as poor man’s MRI”. Various authors have
done studies on sacroiliitis with Colour Doppler Ultrasound and with Power Doppler
US and inferred that Power Doppler US was found to be a useful tool of investigation
in spondyloarthritis,  enthesitis, in diagnosing and in assessing the response to
treatment.  Patients  with  SpA,  need  to  do  scanning  at  multiple  entheseal  sites,  joints
and dactylitis and also after treatment. Power Doppler US is a useful, convenient and
most appropriately, bed side scan than MRI.
Ercument Unlu et al (65) have demonstrated signs of active sacroiliitis  and
the response to anti- TNF therapy with CDDUS. He compared 39 consecutive patients
with AS (24 men, 15 women, mean age 37.3 ± 10.8 yrs, with 14 age and sex matched
controls (8 men, 6 women, mean age 37.2 ± 10.7 yrs) and with 11 AS patients after
anti- TNF therapy (Infliximab in 7 patients and Etanercept in 4 cases). CDDUS
measurements were done before therapy and during the 12th week of therapy. RI
values  were  low  in  sacroiliitis.   Higher  RI  values  were  observed  after  anti-  TNF
treatment. He suggested that, CDDUS may be an alternative, less expensive, and
easier method for detecting inflammation secondary to SI increased spinal
vascularization and in evaluating response to anti-TNF therapy in AS. In our study,
we have compared 108 consecutive patients with SpA (84 men, 24 women, mean age
30 ± 11.10 yrs), with 35 age and sex matched controls (27 men, 8 women, mean age
30 ± 11 yrs), we did only diagnostic Power Doppler US and found low RI in all
patients. The values were  between 0.60 – 1.2 ( in both groups -1& 2). None of our
patients received anti-TNF treatment.
Arslan  et  al (68)  study  with  CDDUS  has  shown  that,  RI  was  similarly
significantly decreased in patients with active sacroiliitis, and increased after
antiinflammatory therapy. However, he has done this study on heterogenous patient
groups which included psoriatic arthritis and tuberculosis and he has not compared
with clinical disease activity parameters and has not used anti – TNF therapy.
Unlike this study, the  Ercument Unlu et al study groups (65) is are
homogenous as he selected only AS patients. In his study, results of CDDUS in
patients with inactive disease was nearly similar to controls. The limitation  in these
two studies is that no comparison was made with MRI. In our study, we have
selected  only  spondyloarthritis  patients  for  whom  we  have  compared  images  of  CT
scan and MRI with Power Doppler US and we have systematically analyzed with
BASDAI and acute phase reactants- ESR and CRP. We have found that MRI and
Power Doppler US was 100% sensitive and 95% specific in diagnosing early
spondyloarthritis. No Power Doppler flow was noted in our controls. We have not
repeated the imaging after NSAID therapy  (figure-6, table-4).
Andrea Klausar et al  (67)  compared   MR  with  microbubble  contrast-
enhanced and non enhanced colour Doppler US in 103 (206 SI joints) patients with
inflammatory back pain and 30 (60 SI joints) controls without inflammatory back
pain. He found that CDDUS was a sensitive technique with negative predictive value
for detection of active sacroiliitis. None of the controls have shown colour flow state
by CDDUS. In our study, we have  similarly  shown  that  Power  Doppler  US  was
sensitive with 100% negative predictive value. Likewise, none of our controls have
shown Doppler flow state. (Figure-6, table-4).
In our study, statistical analysis  ?2, kappa (?)  statistics was done only for 65
cases for whom all three imaging investigations were done and 35 controls were
enrolled only for Power Doppler US. Statistically when “CT- scan was compared
with MRI” the sensitivity of MRI was 100% and specificity 83%, positive predictive
value 8% (PPV), negative predictive value 100% (NPV), accuracy 83% (Ac), kappa
0.11 (?), false positive rate 17% (FPR) and false negative rate 0% (FNR). When
“CT scan was compared with Power Doppler US”  the Power Doppler sensitivity
was 100% and specificity is 85%, PPV25%, NPV  100%, Ac 86%,   0.35%, FPR 15%
and NPR 0%.  “When MRI was compared with Power Doppler US” the sensitivity
was 100%, but specificity increased to 95%.  The other values were as follows -
PPV25%, NPV 100%, Ac 95%,   ?  8%, FPR 5% and NPV was 0%. (table-4).
Here  again,  the  inflammatory  component  may  come  down  as  the  disease
advances, indicating that MRI and Power Doppler may not identify the true
inflammatory lesions. Therefore, to assess the importance of doing imaging in early
spondyloarthritis, study   cases (65 cases) were again divided into two groups. Group
1: Disease duration ? 1 year (33 cases) and group 2: > 1 year (32 cases) and these two
groups were again statistically analyzed and compared for MRI versus Power Doppler
US. In group: 1, both MRI and Power Doppler US was 100% (sensitive & specific)
whereas in group: 2, though MRI/ Power Doppler US was 100 % sensitive, the
specificity decreased to 70%.
In addition, group: 1, patients and their 3 imaging modalities were statistically
analyzed the observation were – CT scan was one time better and MRI was 2.09 times
better than power Doppler. Power Doppler US was 2.20 times better than CT scan and
MRI  in spondyloarthritis with disease duration less than 1 year.
In our study, inflammatory markers like ESR and CRP and the clinical
assessment BASDAI score were correlated and statistically analyzed by single sample
student’s t- test. The mean ESR was 61.80 ± 24.51(minimum 10, maximum 110 mm)
and mean CRP was 16.51± 9.11. The statistical significance of ESR and CRP when
compared with MRI scan was P-0.01 and P-0.05 respectively. The mean BASDAI
was 4.47 ± 1.20, but it was not statistically significant. (P-0.57), whereas in another
published  study  of  patients  with  AS  who  had  active  disease  according  to  BASDAI
score, the ratio of men was higher (p = 0.034), and higher values were recorded for
mean ESR and CRP (65). In various studies, it was demonstrated that anti-TNF
therapy led to regression of SI and spinal inflammation findings on MRI.
Conventional radiography might show chronic spinal changes; however, it does not
give immediate information about response to therapy.
Presence or absence of sacroiliitis as detected by whatever reliable,
reproducible, and affordable method will continue to be a cornerstone for the
diagnosis of SpA/ AS.  Potentially, Power Doppler Ultrasonography may take over as
one of the alternative investigations in patients with spondyloarthritis due to its
relative availability and low cost, and surely may then be a useful tool in diagnosing
and assessing response to therapy. Literature has proved that if diagnosis of
Spondyloarthritis is made early and if treatment is initiated at the appropriate time
with NSAIDs, DMARDs and THE BIOLOGICALS and by early initiation and
maintenance of supervised group physiotherapy, near normal life can be restored.
Conclusions
CONCLUSIONS
? Both MRI and Power Doppler Ultrasound are 100% sensitive in the diagnosis
of sacroiliitis.
? Though MRI scan is a time tested and the best method of detecting sacroiliitis,
the availability of MRI is often limited and the technique is time consuming
and costly, imposing practical difficulties in patients with metal implants, pace
makers and claustrophobia.
? Occasionally closed MRI may not be suitable for obese patients and in severe
inflammatory back pain with limitation of movements of spine.
? CT scan,  a  useful  modality  of  imaging  in  sacroiliitis,  may not  be  suitable  for
early spondyloarthritis (less than 1 yr) and in addition, it is associated with
radiation hazards.
? Power Doppler Ultrasound can be used instead of MRI scan in
spondyloarthritis, preferably with disease duration of less than 1year.
? Power Doppler Ultrasound is a dynamic real time scanning with, absence of
radiation. Multiple joints can be seen on the same day with exact localization
of symptoms, the most important factor being the patient’s acceptance due to
lesser cost. Therefore Power Doppler ultrasound is “Poor Man’s MRI.”
? Power Doppler Ultrasound has become a potent imaging modality in
diagnosing subclinical inflammatory arthritis states and comparison of
ultrasound images with the contralateral side can be done immediately. Hence,
Power Doppler is considered as an “extended arm of the rheumatologist and
rheumatologist’s stethoscope.”
? Power Doppler Ultrasound has proved to be a less time consuming, non
invasive tool for assessing and monitoring the response to therapy at multiple
joints and entheses in a single sitting at the bed side.
? Power Doppler Ultra sound is preferable but cannot replace MRI, because
internal cortical bone pathology cannot be made out by Power Doppler US.
? Despite this, a number of issues including a lack of standardization of Power
Doppler Ultrasound in musculoskeletal disorders, warrant more studies to
satisfy the usefulness of Power Doppler Ultrasound in diagnosing sacroiliitis.
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Appendices
ABBREVIATIONS
SpA                                   Spondyloarthropathies
AS                                     Ankylosing spondylitis
uSpA                                 Undifferentiated spondyloarthropathies
ReA                                   Reactive arthritis
PsA                                    Psoriatic arthritis
IBD arthropathy                 Inflammatory bowel disease related arthropathy
anti- TNF                          Anti- tumor necrosis factor
HLA                                  Human leukocyte antigen
ESSG                                 European Spondyloarthropathy Study Group
CT scan                             Computerized Tomography scan
MRI scan                           Magnetic Resonance Imaging scan
STIR                                  Short Tau Inversion Recovery
T1FSE, T2FSE                 T 1& T 2 Fast Spin Echo
ESR                                   Erythrocyte Sedimentation Rate
CRP                                   C - Reactive Protein
BASDAI                           Bath Ankylosing Spondylitis Disease Activity Index
PDUS                               Power Doppler UltraSound
CDDUS                            Color Duplex and Doppler UltraSound
MSU                                 Musculoskeletal Ultrasound
SIJ                                     Sacroiliac joints
SI                                       Sacroiliitis
TV                                    Thoraco Vertebral
LV                                    Lumbar Vertebral
RI                                     Resistive Index
Master Chart
MASTER CHART - 108 Studied cases but MRI was done only for 65 cases but CT and PD done for all cases
S.No RCC No Age Sex
INF Back
Pain
Duration
in mo Duration of Disease Diagnosis CT Scan MRI Power Doppler ESR/Hr CRP/mg SGOT SGPT SAP X-RAY PELVIS BASDAI
1 50305 17 M + 1 1 Mo ReA Normal SI. Rt-Side SI, Rt.Side, 110 24 34 56 226 Normal 5.2
15 50335 51 M + 1 1 Mo uSpA Bil.SI 0 Bil.SI 90 36 39 43 256 Bil. Gr.1-2 3.4
29 50942 38 M + 12 1 yr AS Bil.SI, R>L 0 Bil.SI 104 12 31 35 159 Bil.Gr.2-3 4.4
85 51044 59 M + 12 1 Yr AS Bil.SI Bil.SI Bil.SI 73 36 21 36 265 Bil.Gr.1-2 5.5
45 OP 43 M + 12 1 yr uSpA Normal Bil. SI Bil.SI 70 12 22 31 188 Normal 2.1
89 50239 29 M + 12 1 Yr uSpA Bil.SI 0 Bil.SI 86 24 27 21 183 Bil.Gr.1-2 5.5
25 OP 23 F + 18 1 yr 6mo uSpA Bil.SI Bil.SI Bil.SI 94 12 36 41 193 Bil.Gr.2 4.4
46 51070 18 M + 18 1 yr 6mo uSpA Bil.SI 0 Bil.SI 51 12 29 34 168 Bil.Gr.2-3 4.5
76 51126 35 M + 18 1 yr 6mo uSpA Bil.SI Bil.SI Bil.SI 84 24 39 23 207 Bil.Gr.2-3 5.5
93 51084 37 F + 18 1 yr 6mo uSpA Bil.SI 0 Normal 28 Neg 29 32 158 SI.Rt.side 3.7
103 OP 21 M + 18 1 yr 6mo uSpA SI.Lt side 0 SI.Lt side 47 12 28 37 156 SI.Lt side 3.7
6 50361 20 M + 12 1 yrs AS Bil.SI, 0 Bil.SI, 70 24 32 39 202 Bil. Gr.2-3 4.1
7 OP 28 M + 12 1 yrs PsA SI, Rt-Side SI, Rt-Side SI,Rt.Side 55 6 23 27 178 SI. Rt side 3.8
75 51127 23 M + 12 1 yrs uSpA Bil.SI Bil.SI Bil.SI 73 6 36 44 166 Bil.Gr.1-2 6.3
16 50386 25 M + 120 10 yrs AS Bil.SI Bil.SI Bil.SI 40 6 24 27 145 Bil.Gr.3-4 4.1
33 19585 40 M + 120 10 yrs AS Bil.SI 0 Bil.SI 66 6 21 19 193 Bil.Gr.2-3 5.6
31 13493 40 M + 120 10 yrs uSpA Bil.SI 0 Normal 31 6 20 31 168 Bil.Gr.2-3 4.1
17 50255 50 M + 156 13 yrs AS Bil.SI, 0 Normal 52 12 18 23 165 Bil.Gr.3-4 4.6
11 19277 35 M + 180 15 yrs AS Bil.SI Bil.SI Bil.SI 45 36 34 28 168 Bil. Gr.2-3 4.8
57 50499 58 M + 180 15 yrs AS Bil.SI 0 Normal 18 Neg 21 27 157 Bil.Gr.3-4 5.8
78 23244 59 F + 180 15 yrs AS Bil.SI Bil.SI Normal 22 Neg 18 23 185 Bil.Gr.2-3 4.6
13 50492 38 F + 216 18 yrs AS Bil.SI Bil.SI Normal 61 12 35 43 203 Bil. Gr.2-3 4.8
30 49672 17 M + 12 1yr uSpA Bil.SI, R>L 0 Bil.SI, R>L 70 24 30 41 207 Bil.Gr.2-3 4.6
94 49786 17 M + 12 1Yr uSpA Normal SI. Lt side SI-Lt side 52 24 28 37 195 Normal 3.7
96 51209 22 F + 18 1yr 6mo ReA Bil.SI 0 Normal 16 Neg 34 39 186 Normal 3.7
36 51088 24 M + 2 2 Mo uSpA SI, Lt-Side 0 Bil.SI, L>R 41 24 34 31 195 Normal 3.1
5 50426 21 M + 24 2 yrs AS Bil.SI, Bil.SI, R>L Bil.SI, 41 36 18 24 186 Bil. Gr.2-3 4.2
22 50202 38 M + 24 2 yrs AS Bil.SI Bil.SI Bil.SI 62 12 34 28 174 Bil.Gr.2-3 5.6
66 48202 27 M + 24 2 Yrs AS Bil.SI 0 Bil-SI 82 24 28 31 178 Bil.Gr.2-3 4.6
88 op 40 M + 24 2 Yrs AS Bil.SI Bil. SI Bil.SI 64 6 23 34 225 Bil.Gr.2-3 5.5
95 op 35 M + 24 2 yrs AS Bil.SI Bil. SI Bil.SI 77 6 38 31 206 Bil.Gr.2-3 5.5
99 51222 35 M + 24 2 Yrs AS Bil.SI 0 Bil.SI 76 12 27 35 189 Bil.Gr.2-3 5.5
108 OP 29 M  + 24 2 Yrs PsA Normal 0 SI.Rt side 35 6 31 27 163 Normal 3.3
3 50412 19  M + 24 2 yrs uSpA SI, Rt-Side SI, Rt-Side Bil.SI, 60 16 22 30 136 Gr.3 on Rt 4
23 OP 28  M + 24 2 yrs uSpA Bil.SI, R>L Bil. SI Bil.SI 75 12 23 33 180 Bil.Gr.2-3 5.4
37 51066 25  M + 24 2 yrs uSpA Bil.SI, L>R Bil.SI, L>R Bil.SI, L>R 76 12 32 28 176 Bil.Gr.2 4.1
41 51014 21  M + 24 2 yrs uSpA Bil.SI, R>L Bil.SI, R>L Bil.SI, R>L 35 6 33 37 181 SI.Rt.side 4.1
53 51113 34  F  + 24 2 Yrs uSpA BIL. SI 0 SI.Rt-side 27 12 39 25 173 Bil. Gr.1-2 3.7
69 48915 20  M  + 24 2 Yrs uSpA Bil.SI 0 Bil-SI 52 12 31 39 169 Bil.Gr.2-3 4.2
70 50412 19  M  + 24 2 Yrs uSpA Bil.SI Bil. SI Bil-SI 75 6 24 32 199 Bil.Gr.2-3 5.5
74 44250 19  F  + 24 2 Yrs uSpA Bil.SI 0 Bil.SI 62 6 21 19 203 Bil.Gr.1-2 5.5
79 51132 19  M  + 24 2 Yrs uSpA Bil.SI Bil.SI Bil.SI 60 24 28 31 224 Bil.Gr.2-3 5.5
82 51130 24  M  + 24 2 Yrs uSpA SI. Lt side SI. Lt-Side Bil.SI 52 18 29 33 192 SI.Lt side 3.7
90 OP 28  F  + 24 2 Yrs uSpA Bil.SI Bil. SI Bil.SI 90 36 34 32 175 Bil.Gr.2-3 8
104 OP 28  F  + 24 2 Yrs uSpA Bil.SI Bil. SI Bil.SI 25 6 22 39 209 Bil.Gr.2-3 5.5
8 19585 40  M + 240 20 yrs AS Bil.SI 0 Normal 43 12 44 35 226 Bil. Gr.2-3 5.6
40 50994 50  M + 240 20 yrs AS Bil.SI, 0 Normal 20 Neg 23 19 166 Bil.Gr.3-4 6.8
62 50221 40  M  + 264 22 Yrs uSpA Bil.SI 0 Normal 22 Neg 22 18 171 Bil. Gr.3-4 7.6
81 23244 59  F  + 276 23 Yrs AS Bil.SI Bil.SI Normal 10 Neg 21 27 223 Bil.Gr.3-4 3.7
77 op 53  F  + 3 3 Mo PsA SI. Lt side Bil. SI Bil.SI 53 12 21 27 259 suspicious 3.7
20 50063 18  M + 3 3 Mo ReA SI, Rt-Side SI, Rt-Side Bil.SI 87 12 33 48 195 Normal 3.1
100 OP 24  M  + 3 3 Mo ReA Normal Normal SI.Rt side 35 6 18 25 167 Normal 3.7
101 op 34  M  + 3 3 Mo ReA SI. Rt side 0 SI.lt side 72 12 40 56 244 SI.Rt.side 4.5
18 50258 21  M + 3 3 Mo uSpA Bil.SI Bil.SI Bil.SI 92 24 29 23 184 Bil.Gr.3-4 4.2
19 50243 21  M + 3 3 Mo uSpA Bil.SI, L>R Bil.SI Bil.SI, L>R 102 12 24 32 178 Bil.L>R.Gr.2-3 4.6
39 50948 19  M + 3 3 Mo uSpA Bil.SI, R>L Bil.SI, R>L Bil.SI, R>L 94 24 28 23 182 SI.Rt.side 3.2
47 OP 18  M  + 3 3 mo uSpA Normal Bil. SI Bil SI 102 36 17 20 196 Normal 3.1
55 OP 17  M  + 3 3 Mo uSpA Normal Bil.SI BIL.SI 83 36 19 34 257 suspicious 5.7
59 50450 20  M  + 3 3 Mo uSpA SI, Rt-Side Bil. SI Bil.SI 73 36 29 34 187 Normal 1.3
67 47954 21  M  + 3 3 Mo uSpA SI. Rt-Side 0 Bil-SI 57 6 26 35 203 Normal 3.7
72 op 16  F  + 3 3 Mo uSpA Bil.SI Bil.SI Bil.SI 110 24 33 39 261 Bil.Gr.1-2 3.7
4 50450 20  M + 36 3 yrs AS Bil.SI 0 SI, Rt-Side, 83 6 31 36 206 Bil. Gr.2-3 4.8
27 50951 20  M + 36 3 yrs AS Bil.SI Bil.SI Bil.SI 56 12 34 37 190 Bil.Gr.2-3 4.3
56 op 35  M  + 36 3 yrs AS Bil.SI Bil. SI Bil-SI 70 12 23 39 166 Bil. Gr.2-3 5.5
96 OP 32  M  + 36 3 yrs AS Bil.SI 0 Bil.SI 57 12 19 31 193 Bil.Gr.2-3 5.5
32 50974 28  M + 36 3 yrs ReA SI, Rt-Side Bil. SI Bil.SI, R>L 53 12 33 29 173 SI.Rt.side 3.1
54 RCC 26  M  + 36 3 yrs uSpA Normal SI, Lt-Side Bil-SI 102 36 34 41 180 Normal 5.5
73 op 20  M  + 36 3 yrs uSpA Bil.SI Bil.SI Bil.SI 21 Neg 28 41 190 Bil.Gr.2-3 3.6
86 OP 21  M  + 4 4 Mo ReA SI. Lt side 0 Bil.SI 41 12 37 29 188 suspicious 3.7
60 50395 17  M  + 4 4 Mo uSpA SI, Rt-Side 0 Bil.SI 64 24 25 21 234 Normal 2.7
80 51138 35  M  + 4 4 Mo uSpA Bil.SI Bil.SI Bil.SI 85 12 32 39 178 Bil.Gr.1-2 3.7
106 OP 40 M  + 4 4 Mo uSpA SI.Lt side SI. Lt side SI. Lt.side 86 12 18 21 187 Normal 3.3
26 49892 22  F + 48 4 yrs uSpA Bil.SI 0 Bil.SI, L>R 83 24 24 31 234 Bil.Gr.2-3 4.2
35 51041 36  M + 48 4 yrs uSpA Bil.SI, L>R Bil.SI Bil.SI 106 24 25 31 187 Bil.Gr.3 6.8
65 48109 48  M  + 48 4 yrs uSpA Bil.SI 0 Bil-SI 53 Neg 24 17 201 Bil.Gr.2-3 5.5
68 48143 23  M  + 5 5 Mo ReA SI. Rt-Side 0 SI.Rt side 70 12 35 27 197 suspicious 3.7
34 57072 40 M + 60 5 yrs AS Bil.SI 0 Bil.SI 75 12 31 28 197 Bil.Gr.2-3 4.8
52 51060 30  M  + 60 5 yrs AS BIL. SI Bil. SI Bil. SI 50 6 18 24 181 Bil.Gr.2-3 5.5
64 50477 42 M  + 60 5 yrs AS Bil.SI 0 Bil-SI 42 6 31 29 177 Bil.Gr.2-3 5.5
28 44780 30  M + 60 5 yrs PsA Bil.SI, L>R 0 Bil.SI 92 12 27 38 175 Bil.Gr.2-3 4.3
10 49724 21  F + 60 5 yrs uSpA SI, Rt-Side SI, Rt-Side SI,Rt.Side, 81 12 30 24 176 SI. Rt side 4.8
42 OP 53  F + 6 6 Mo PsA Normal SI. Lt. side SI, Lt-Side 25 12 26 31 170 Normal 3.5
102 op 44  F  + 6 6 Mo PsA Bil.SI Bil.SI SI.Rt side 39 24 38 23 189 SI.Rt.side 3.7
14 42885 17  F + 6 6 mo ReA SI-Lt Side SI,Lt-Side Bil.SI 84 24 42 56 189 sI. Lt side 3.5
24 OP 35  F + 6 6 Mo ReA SI, Lt-Side 0 Bil.SI, L>R 55 12 21 37 156 Normal 4.1
92 OP 40  F  + 6 6 Mo ReA Bil.SI Bil. SI Bil.SI 52 12 37 56 196 Bil.Gr.1-2 5.5
105 OP 18  M  + 6 6 Mo ReA SI. Rt side 0 SI. Rt side 36 12 27 33 188 SI.Rt.side 3.7
21 50153 17  M + 6 6 Mo uSpA SI, Rt-Side 0 Bil.SI, R>L 40 24 35 31 203 SI.Rt.side 3.6
43 OP 31  M + 6 6 Mo uSpA Normal SI, Rt-Side SI, Rt-Side 66 12 28 23 191 Normal 1.8
44 OP 25  F + 6 6 Mo uSpA Normal SI.Rt.side SI, Rt-Side 75 24 37 24 179 Normal 2.8
49 51107 31  M  + 6 6 Mo uSpA BIL SI Bil. SI Bil SI 80 24 19 31 189 Bil. Gr.1-2 3.7
50 OP 17  M  + 6 6 Mo uSpA BIL. SI Bil. SI Bil.SI 52 12 34 29 174 Bil.Gr.1-2 3.7
58 50426 21  M  + 6 6 Mo uSpA Bil.SI 0 Bil.SI 82 36 31 28 209 SI.Rt.side 3.7
61 50487 19  M  + 6 6 Mo uSpA SI. Rt-Side Bil. SI Bil.SI 51 12 30 27 211 SI.Rt.side 3.7
63 49724 21 F  + 6 6 Mo uSpA Normal Bil. SI Bil.SI 60 12 29 34 185 Normal 3.7
83 51155 39  M  + 6 6 Mo uSpA SI. Rt-Side SI. Rt-Side Bil.SI 82 12 26 39 209 SI.Rt.side 5.5
84 51157 21  M  + 6 6 Mo uSpA SI. Lt side SI. Lt side Bil.SI 95 12 31 28 177 SI.Lt side 4.5
87 51107 31  M  + 6 6 Mo uSpA Bil.SI Bil.SI Bil.SI 53 12 31 24 221 Bil.Gr.1-2 5.5
91 op 33  M  + 6 6 Mo uSpA Bil.SI Bil. SI Bil.SI 75 24 35 27 198 Bil.Gr.1-2 5.5
107 op 32 F  + 6 6 Mo uSpA SI. Rt side 0 Normal 48 6 24 21 156 Normal 3.3
98 51220 21  M  + 6 6 Mon uSpA SI. Lt side 0 Bil.SI 52 24 22 39 203 SI.Lt side 5.1
48 OP 40  F  + 72 6 yrs uSpA Normal Bil. SI Bil SI 42 24 27 33 174 Normal 1.5
71 op 21  F  + 6 6mo uSpA Bil.SI Bil. SI Bil.SI 96 24 29 48 258 Bil.Gr.1-2 5.7
2 50386 25  M + 84 7 yrs AS Bil.SI 0 Bil.SI, 25 12 28 21 Gr. 3-4 5.6
9 50477 42  M + 84 7 yrs AS Bil.SI, R>L Bil.SI, R>L Bil.SI, R>L 106 24 34 33 209 Bil. Gr.2-3 5.5
12 50570 28  M + 84 7 yrs AS Bil.SI Bil.SI Bil.SI 53 12 42 35 180 Bil. Gr.2-3 4.1
51 43497 22  M  + 228 7 yrs AS BIL. SI 0 Bil. SI 27 12 26 39 178 Bil. Gr.2-3 4.1
38 51056 24  M + 96 8 yrs AS Bil.SI, L>R Bil.SI, L>R Bil.SI, L>R 23 Neg 18 12 160 Bil.Gr.3-4 8.2



